ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0001439.1|Cervimycin_1 # 2 # 1282 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0001439.1|Cervimycin_1 	2	1282	+	Loose	750	182.956	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	32.68	3003463	protein variant model	F413L	n/a	isoniazid	antibiotic target alteration	antibiotic resistant kasA	GTGTCAGGACGACACGATGCTCGGCGCGTCGTGGTGACAGGGATCGGCGTGATCGCGCCCGGGGGAATCGGTACGAAGCAGTTTTGGGAGCTGCTGTGCGCCGGGCGCACCGCGACGCGCACCATTTCCCTGTTCGACGCGAGCGAGTTCCGCTCGAGAGTGGCCGCGGAATGCGATTTCGATCCCGTCGCCTCGGGGCTGAGTCAGCGGGAGATCCGCAGATGGGACCGGACCACGCAGTTCGCGGTGGTCGCCGCCAAGGAGGCACTGGACGACAGCGGTGTGCTGGGCGAGACGGACCCGTACCGCACGGGTGTCATGGTCGGCACGGCCTGCGGCATGACGCGGAGCCTGGACCGCGAGTACGCCGTCGTCAGTGACAACGGCAGGAAATGGCACGTCGACGAGGCGCACGGCTCGCCCTACCTCTACGACTACTTCGCGCCCTCGTCCATGGCCGCCGAACTCGCCTGGCTGGCGGAGGCGCAAGGGCCCGTCGGCGTCATCTCGACGGGCTGCACCTCCGGCATCGACGTGCTCGGCCACGCCGCCGACCTCATCATCGACGGGGCGGCGGACGTCATGATCAGCGGCGCCTCCGACGCCGCCATCTCGCCGATCACCGTGGCGTGCTTCGACGCGATCCGGGCGACCACACCGCGCAACGACGATCCGGCGACCGCGTCCCGCCCCTTCGACCGGACACGCAACGGGTTCGCGCTCGGCGAGGGTTCCGCGATCCTCGTCCTGGAGGAGTACGGGCACGCCCGCCGCCGCGGCGCCCGGGTCTACGCCGAGGTCGCGGGCCACGCGACCCGCGCGAACGCCTTCAGCATGACCGGACTGCGCCCGGACGGCAGGGAACTGGCCGAGGCCATCACCGTGGCCCTCGACCGTGCCGAGGCGAACCCGTCCGACATCGGATACATCAACGCGCACGGCTCGTCGACCAAGCAGAACGACCTGCACGAGACGATGGCGTACAAGCGCAGCCTCGGCGAGCACGCCTACCGGGCCCCCATCAGTTCGATCAAGTCGATGATCGGGCACTCCCTGGGAGCGATCTGCGCGCTGGAGGTGGCCGCCTCCGTACTCGCCATCGAACACTCGGTGATTCCGCCGACGGCCAACCTGCACGAGCCCGATCCCGCGTGCGACCTCGACTACGTGCCGTTGGTGGCCCGCGAACAGCCGTCCGACGTGGTGCTCAGCGTGGCCAGCGGATTCGGCGGCTTCCAGAGCGCGATGGTGCTGACCGCACCGGATTGGACCGCACCATGA	VSGRHDARRVVVTGIGVIAPGGIGTKQFWELLCAGRTATRTISLFDASEFRSRVAAECDFDPVASGLSQREIRRWDRTTQFAVVAAKEALDDSGVLGETDPYRTGVMVGTACGMTRSLDREYAVVSDNGRKWHVDEAHGSPYLYDYFAPSSMAAELAWLAEAQGPVGVISTGCTSGIDVLGHAADLIIDGAADVMISGASDAAISPITVACFDAIRATTPRNDDPATASRPFDRTRNGFALGEGSAILVLEEYGHARRRGARVYAEVAGHATRANAFSMTGLRPDGRELAEAITVALDRAEANPSDIGYINAHGSSTKQNDLHETMAYKRSLGEHAYRAPISSIKSMIGHSLGAICALEVAASVLAIEHSVIPPTANLHEPDPACDLDYVPLVAREQPSDVVLSVASGFGGFQSAMVLTAPDWTAP	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.40	gnl|BL_ORD_ID|2018|hsp_num:0	1943		
BGC0001439.1|Cervimycin_2 # 1279 # 2496 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=CCG;rbs_spacer=14bp;gc_cont=0.735	BGC0001439.1|Cervimycin_2 	1279	2496	+	Loose	300	24.6386	AAC(3)-IIc	43.75	3002535	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGAGCGCGCCCGTGATCACCGGACTGGGCACGGTCTCCCCGAACGGGCTGGGCACGGAGGCCTACTGGTCGGCCACCCTGCGCGGCGAGAGCGGCATCGGTCCGATCACCCGGTTCGAGCCGGACGGGTACCGCGGCCGAACGGGCGGCGAGGTCAAGGACTTCGAGCCGAAGGAGCACCTGCCGAGCAGACTTCTGCCGCAGACGGACCACATGACCCGCCTCGCGCTGGTCGCCGCCGAGGAGGCGCTGTCCGACGCGGGCATCGACCCCGACGCACTCCCGGACTTCGCGATGGGCGTGGTGACCGCGGCGTCCGCGGGCGGGATGGAGTTCGGGCAGCGGGAGATGGAGGCGCTCTGGAGCAAGGGCGGCGCCTACGTGAGCTCGTATCAGGCGTTCGCCTGGTTCTACCCGGTCAACACCGGCCAGATCTCCATCCGGCACGGCCTGCGCGGTGCGAGCTCGGCCGTCGTCACCGAACAGGCCGGCGGACTCGACGCCGTCGCCAAGGCCCGGCGGCACATCCGCCAGGGCACCCCGCAGATGCTCGCCGGCGGCGTCGACAGCGCTCTGTGCCCCTGGGGCTGGCTGTGCATGTCCCGCTCCGGGCGGGTGTCCACGGTGGAGGACCCGGCCCGGGCGTATGTGCCCTTCGACACCGGGGCCTCGGGCTATGTGCCGGGGGAGGGCGGCGCACTGCTGGTCATGGAGGACGGGGCGGCGGCCGCCCGGCGTGGCGCGGACAAGCCGTACGGAGCCGTGGCGGGCTACGCGTCGACGTTCGACCCGCGGCCCGGCAGCGATCAGGAGCCCGGCCTGAGGCGGGCCCTGGAGATGGCCCTGGCCCAGGCACGGATCACGCCCGCCGACATCGACCTCGTGTATGCCGACGCCTGCGGCGTGCCCGAACTGGACCTGGTGGAGGCCGAGACGCTGGCCCGGGTGTTCGGGCCCCGGGGCGTGCCCGTGACCGCTCCCAAGACGATGACGGGACGGCTGCTCGCCGGAGGCGCCTCGCTCGACCTCGCGACGGCCCTGCTGTCCCTGCGCGACCAGGTCGTCCCGCCCACGGTGAACATCGACCGGCCGGCTCACGGCCGGCTCATCGACCTGGTCGTGGGTGAGCCGCGCGAGGCCCGGCTCACCCACGCCCTGGTCCTCGCGCGCGGCTATGGCGGATTCAACTCCGCCATGGTCGTCAGGCGCGAGGCCTGA	MSAPVITGLGTVSPNGLGTEAYWSATLRGESGIGPITRFEPDGYRGRTGGEVKDFEPKEHLPSRLLPQTDHMTRLALVAAEEALSDAGIDPDALPDFAMGVVTAASAGGMEFGQREMEALWSKGGAYVSSYQAFAWFYPVNTGQISIRHGLRGASSAVVTEQAGGLDAVAKARRHIRQGTPQMLAGGVDSALCPWGWLCMSRSGRVSTVEDPARAYVPFDTGASGYVPGEGGALLVMEDGAAAARRGADKPYGAVAGYASTFDPRPGSDQEPGLRRALEMALAQARITPADIDLVYADACGVPELDLVEAETLARVFGPRGVPVTAPKTMTGRLLAGGASLDLATALLSLRDQVVPPTVNIDRPAHGRLIDLVVGEPREARLTHALVLARGYGGFNSAMVVRREA	MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYASWDRSPYEETRNGARLDDKTRRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASMVAVGPLAETLTEPHKLGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPNKRRVTYEMPMLGSNGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGVVGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPAHEVAECSCEPSG	141.61	gnl|BL_ORD_ID|1294|hsp_num:0	1378		
BGC0001439.1|Cervimycin_3 # 2576 # 2833 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.647	BGC0001439.1|Cervimycin_3 	2576	2833	+	Loose	1900	25.409	MexW	28.3	3003031	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCGCCTTCGGCGTCAAGGAACTCGTGGACGTCCTGCGCGAGAGCGCTGGTGAGGACGAGGACGTCAGCCTCGAAGGAGACATCCTCGATGTCGACTTCGAGTCGCTCGGCTACGACTCGCTCGCCCTGTTCAACACGGTGCGGTGGATCGAGCGTGATCTCGGCATCACCCTGTCCGACGAGGCCATCGACGTCGAGGGAACGCCGCGTGCCCTCCTGGACGAGATCACCAAGGCGGCCACCCAGTCGGTCTGA	MAAFGVKELVDVLRESAGEDEDVSLEGDILDVDFESLGYDSLALFNTVRWIERDLGITLSDEAIDVEGTPRALLDEITKAATQSV	MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH	8.35	gnl|BL_ORD_ID|2063|hsp_num:0	2208		
BGC0001439.1|Cervimycin_4 # 2939 # 4708 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=CCG;rbs_spacer=15bp;gc_cont=0.722	BGC0001439.1|Cervimycin_4 	2939	4708	+	Loose	1300	26.1794	optrA	37.93	3003746	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGACGGACGTCCTGGCGTGCCGGGGCCCCGACGACGAGGGGATCTTCTCGGCGCGCCGGGTCGTGCTCGGCCACCGCAGGCTGTCCGTCATCGACCGGGCGGGCGGCGCCCAGCCCATGACGTACGACGTCGGCGGCGGCACGGTGGTCGCCCTGACGTTCTGCGGGGAGGTCTACAACTTCCGGGAGCTGCGCGCGGAACTGGCCGCCAAGGGGCACGTCTTCCGCACCCGGAGCGACACCGAGGTGGTCCTGCACGCCTATCTGGAGTGGGGCGAGGCACTGGCCGACCGGCTCAACGGCATGTACGCCTTCGGGGTCTGGGACGCCAGGACCGAGGAACTGCTCCTCGTGCGCGACCGCATGGGCGTCAAGCCGCTCTACTACCACGAGACCGGGCACGGCATCGTCTTCGGCTCCGAGCCCAAGGCGCTCTTCGCCCACCCGGCCGTCCCGCGCACCGTGGACGTCGAAGGGCTCTGCGAGGCCCTGGACATGGTGAAGACCCCGGAGCAGGCGGTCTTCTCCGCACTGCGGGAGGTACGGCCCGGCCAACTGCTGCGCGTGCGCCGGCAGGGCACGGTGCGGCGCCGGTACTGGACCCTGGAGGCGAGGGAGCACCCGGACGACCTCCGGACCACCATCGGCACCGTCCGCGGACTGCTCGAGGACATCGTGTCCCGCCAGCTGATCTCCGACGTACCGCTGTGCACGCTGCTGTCGGGCGGTCTCGACTCGTCCGCGGTGACGGCGCTCGCGGCGGCTCAAAGCGCGTCCGCCGTGCGGTCGTTCTCCGTGGACTTCTCCTCGCACGGACGCGAGTTCGCGCCGGACGCGGTGCGCTCGTCCCCGGACGCGCCGTTCGCCGTCGAGCTGGCCGCCCACGTCGGCGCCGAGCACACCGAGGTGCTGCTGGACAGCGCGGACCTGGTCGACCCGCGGGTGCGGGCCGCGGTCCTGAGGGCCACCGACCTGCCCCCGGCGTTCTGGGGCGACATGTGGCCGTCCCTGTACCTGCTGTTCCGTGCCGTCCGGCAGCGGTCGACGGTGGCGCTGTCCGGAGAGTCCGCGGACGAGCTGTTCGGCGGCTACCTCTGGTTCCGCAACCCGCGCGCGATCGCCGCCGACACCTTCCCCTGGCTCACCTCGGGATCGGCCCGCTACTTCGGCGGACTCGGCCTGCTCGACCCGGGCCTGCTGGAGAAGCTGGACATCCCCGGCTATCGCGCGGCCCGCTACCGGGAGGCGCTGGCCGAGGTCCCGGTCCTGCCCGGCGAGGACGCCACCGAGCGCCGGATGCGGGAGATCACGTATCTCAACCTCACCCGGTTCGTGCAGACGCTCCTCGACCGCAAGGACCGGATGAGCATGGCCGTCGGGCTGGAGGTCCGGGTGCCGTTCTGCGACCACCGGCTGGTGGAGTACGTCTTCAACGTCCCCTGGGCGATGAAGACCTTCGACGGCCGGGAGAAGAGCCTGCTGCGCGCCGCGACCGCCGATCTGCTGCCGGCGTCGATCCTCCGGCGGCAGAAGACACCGTACCCGGCCACGCAGGACCCGCACTACGAGCTGGCCCTGCGCGCCGAGCTGTCCGAGGTGCTGGCGGACCCGGACGCCCCGGTACGGCCGTTGCTGGACCTCGGCCGGGCGCGGAGCACCCTGGACCGCGTACCCGGCGACGTCAGCAGGCCCTACGCGCGCGGCGGGATCGAGATGGCCCTGTGGCTCAACGCGTGGCTGCGCGCGTACGACGTGACCCTCGCCATCTGA	MTDVLACRGPDDEGIFSARRVVLGHRRLSVIDRAGGAQPMTYDVGGGTVVALTFCGEVYNFRELRAELAAKGHVFRTRSDTEVVLHAYLEWGEALADRLNGMYAFGVWDARTEELLLVRDRMGVKPLYYHETGHGIVFGSEPKALFAHPAVPRTVDVEGLCEALDMVKTPEQAVFSALREVRPGQLLRVRRQGTVRRRYWTLEAREHPDDLRTTIGTVRGLLEDIVSRQLISDVPLCTLLSGGLDSSAVTALAAAQSASAVRSFSVDFSSHGREFAPDAVRSSPDAPFAVELAAHVGAEHTEVLLDSADLVDPRVRAAVLRATDLPPAFWGDMWPSLYLLFRAVRQRSTVALSGESADELFGGYLWFRNPRAIAADTFPWLTSGSARYFGGLGLLDPGLLEKLDIPGYRAARYREALAEVPVLPGEDATERRMREITYLNLTRFVQTLLDRKDRMSMAVGLEVRVPFCDHRLVEYVFNVPWAMKTFDGREKSLLRAATADLLPASILRRQKTPYPATQDPHYELALRAELSEVLADPDAPVRPLLDLGRARSTLDRVPGDVSRPYARGGIEMALWLNAWLRAYDVTLAI	MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM	89.92	gnl|BL_ORD_ID|2118|hsp_num:0	2263		
BGC0001439.1|Cervimycin_5 # 4805 # 6112 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.688	BGC0001439.1|Cervimycin_5 	4805	6112	-	Loose	750	24.6386	tet(53)	25.32	3004589	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGCCGGCGAGGCCAAACGGCTCATTCTTGAATCGGTGGCGAAATACCATCAGGAGGCCACCGGGGACACGGAGTTCATACCCGGGGTCACCCCGGTACTGCCGTCCGGGGCGGTACTCGCCGCCGAGGACCGGGTGGCGCTGGTGGAGGCGGCGCTGGACATGCGCATCGCCGCGGGCGTGAGCTCGCGGAGGTTCGAGCGGCAGTTCGCCAAGGCGCTCGGGCTGCGCAAGGCGCACCTGACCAACTCCGGTTCCTCGGCGAACCTGCTGGCCCTGTCGTCCCTCACCTCGCCCCAGCTCGGGGACCGCAGGATGAAGCCGGGCGACGAAGTGATCACCGTCGCGGCGGGCTTTCCCACCACGGTCAACCCGATCTACCAGAACGGGATGACACCGGTCTTCGTCGATGTCGAACTGGGCACCTACAACGCCACGGCGGAGCGGGTCGCGGCCGCGATCGGCCCGAAGACCAGGGCCATCATGATCGCCCACGCGCTCGGCAACCCGTACGAGGTGGACGAGATCGCCCGGCTCGCCGAGGAGCACGACCTGTTCCTCGTCGAGGACAACTGCGACGCGGTGGGGTCCCTGCACCGCGGCAGGTTCACCGGCACCTTCGGCGACCTCGCCACGACGAGCTTCTATCCGGCGCACCACATCACCACCGGCGAGGGCGGCTGCGTACTCACCGACAACCTGGTGCTGGCCAGGATCGTCGAGTCGATGCGCGACTGGGGCCGGGACTGCTGGTGCGAACCGGGTGAGGACGACACCTGCCACAAGCGGTTCAAGTACCAGCTCGGCGACCTGCCGCCGCAGTACGACCACAAGTACACGTTCTCCCACGTCGGTTACAACCTGAAGGGCACCGACGTCCAGGCCGCGCTGGGCATCACGCAGCTCACCCGGCTCGAGGAGTTCGGTGCCGCGCGACGGCGCAACTGGCGGCGGCTGCGCGACGGTCTGGAGGGCACCCCGGGCTTCCTGCTGCCCACCGCCACACCCGGCAGCGACCCCAGCTGGTTCGGGTTCGCGATCACGCTGACCGAGGACGCCGGGTACGACCGTTACGAGCTGCTGCGTTTCCTCGGCGACCGCAGGATCGGCACCCGGCTGCTGTTCGCGGGCAATCTGACCCGCCACCCGGGCTATCTCGACCGCGAGTTCCGGGTGGTCGGCGACCTCACCAACAGCGACGTCATCCTCGAGCGGACCTTCTGGGTGGGTGTGTACCCGGGGCTGACCAGCGAGATGATCGACTACGTGGCCGCGTCGCTGCGGGAGTTCGCCCGCGGGGCACGCTGA	MAGEAKRLILESVAKYHQEATGDTEFIPGVTPVLPSGAVLAAEDRVALVEAALDMRIAAGVSSRRFERQFAKALGLRKAHLTNSGSSANLLALSSLTSPQLGDRRMKPGDEVITVAAGFPTTVNPIYQNGMTPVFVDVELGTYNATAERVAAAIGPKTRAIMIAHALGNPYEVDEIARLAEEHDLFLVEDNCDAVGSLHRGRFTGTFGDLATTSFYPAHHITTGEGGCVLTDNLVLARIVESMRDWGRDCWCEPGEDDTCHKRFKYQLGDLPPQYDHKYTFSHVGYNLKGTDVQAALGITQLTRLEEFGAARRRNWRRLRDGLEGTPGFLLPTATPGSDPSWFGFAITLTEDAGYDRYELLRFLGDRRIGTRLLFAGNLTRHPGYLDREFRVVGDLTNSDVILERTFWVGVYPGLTSEMIDYVAASLREFARGAR	MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE	112.40	gnl|BL_ORD_ID|2782|hsp_num:0	3290		
BGC0001439.1|Cervimycin_6 # 6347 # 7306 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=CCG;rbs_spacer=14bp;gc_cont=0.744	BGC0001439.1|Cervimycin_6 	6347	7306	+	Loose	500	28.1054	FAR-1	35.14	3004784	protein homolog model	n/a	n/a	penam	antibiotic inactivation	FAR beta-lactamase	ATGGCCGGTCTGCTGGATCCGGCGCGGAGCAAGCTGCGCGGGATCGAGTCGGTCACGGTGGCGTCCGACGCCGAGGAGGACGCCCCGCCGCGGATGGCGGCGCGAGCGGCCCGTGCGGCGCTCGGCCGCGGGGACGTCGACCCGGCCGACGTCTCCCTGGTGCTGCACAGCTCGCTGTGGTTCCAGGGCATCGACCTGTGGCCGGCGGCCAGTTACGTCGCCCACGAGGCCGTCGGACGCCATGTGCCGGCCTTCGGCCTGGCCCAGCGCTGCAACGGCGGGATGGGAGCCATCGAGCTGGCCGGGGCCTACCTCGGGTCGGGCATCGGTGCCGGACACGCCGCCCTGCTCACCACGGGTGACCGCTTCGCCGGCCCGCGCATCGACCGCTGGAACAGCGTCGACGTGACGATGTACGGCGACGGCGCCGCCGCGCTGGTGCTGTCGACGCGCGACGGCTTCGCCCGGGTGCTGTCCACGGCCACGGGTGTGGACAACTCGCTGGAGATCCTGGCACGGGGCGACGAGCCGTTCGCCCCGCACCCGGTCGAGCCGTCACCGGTGGCCGACCTGGGCACGCGGACGGTCCGCGGCGCGGAGCTCGCGGACCTGCCCGACCTCACCCACCGCTACATCGACCTGCTGGTGGCGGCGAAGACGCAGGCCCTCGAGGACGCCGGCACCGCCATCGAGGACATCGCCCACGCGGTCATCCCGGTTTCCCGGCGGGGCACCGGCCACGAGCTGCACGACCTGCTCGGCCTGCCGGACGAGCGCACCTCCTGGGCGTACGGGCGCACCACGGGCCATGTCGGTGCGGGCGACCAGTACGCGGGGCTCGCCCACCTCGTGGAGAACGCGTTGGTCCAGCCCGGCGACCGGGTGCTGCTGTTCGGCGGCGGCGCGGGCTACACCTGCACCGCCGCGGTGGTCGAGATACTCCGGATGCCCGCGCACTGA	MAGLLDPARSKLRGIESVTVASDAEEDAPPRMAARAARAALGRGDVDPADVSLVLHSSLWFQGIDLWPAASYVAHEAVGRHVPAFGLAQRCNGGMGAIELAGAYLGSGIGAGHAALLTTGDRFAGPRIDRWNSVDVTMYGDGAAALVLSTRDGFARVLSTATGVDNSLEILARGDEPFAPHPVEPSPVADLGTRTVRGAELADLPDLTHRYIDLLVAAKTQALEDAGTAIEDIAHAVIPVSRRGTGHELHDLLGLPDERTSWAYGRTTGHVGAGDQYAGLAHLVENALVQPGDRVLLFGGGAGYTCTAAVVEILRMPAH	MAAAAAIALLGGCGADAGSEPATTAASTTAPSTATDAATAEFAALEQRSGARLGVYAVDTTSGAEVAYRADERFGMASTFKGLACGALLREHPLSSGYFDQVVRYSREEVVSYSPVTETRVDTGMTVAELCHATITVSDNTAGNQILKLLGGPAGFTAFLRSLGDEVSRLDRWETELNEVPPGEERDTTTPAAVAANYRALVLGDVLAEPERAQLRDWLVANTTGDQRIRAGVPAGWTVGDKTGGGSHGGNNDVAVAWTETGDPIVIALLSHRTDPAAKADNALLAEATRAVVTALR	107.41	gnl|BL_ORD_ID|2156|hsp_num:0	3583		
BGC0001439.1|Cervimycin_7 # 7331 # 8092 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0001439.1|Cervimycin_7 	7331	8092	-	Loose	500	25.7942	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	36.17	3003393	protein variant model	I194T	n/a	isoniazid	antibiotic target alteration	isoniazid resistant inhA	ATGGACATGGGACTGGGCGACCGCACCGTACTGGTGACCGGCGGGAGCAAGGGGATCGGGCTCGCGGTGGCTCGGGCGTACTCCGCCGAGGGCGCGCGGGTGGCGCTCACCTACCGGTCGGACGAGGAGGCGGCCGCCCGGGCCGCGGCCGAACTGGGCGCGGCCGACGGCCGCGCCTGCCATCTGCGCTACGCGCTGGACGAGCCGGGCTCGCCGGAGACCGTCGTCGACGAGGTGTGCGCCCGGTGGGGCGGACTCGACGTCCTGGTGGCCAACGCCCTGGTACGCCCGCGGCGCCGGACGCCGAACGAGCGGTTCGAGGACCTGCCGCCGGCCGAGTGGGAGCCGCTGCTGAGTGGAAACGTCGCCGGGACCGTGCGCACCACGCAGCTGGCGCTGGCCCGGATGCGCAAGCAGGGGTGGGGGCGCATCGTCTTCGTGTCCTCCCATGTCGCGGTCGACGGCAAGCCGCGCCAGGAGATCTACGGCGCCGCGAAGATGGCACTGCACGGACTGATGCGGAGCATGGCGTGGGACGCGGGCCGCGACGGCGTGCTGGTGAACGTCGTCAGCCCCGGACTGACCCTGACGGAAGGCGTCCGCACCGTACTGCCGGGTGAGGTACGGGAGGAGGAGCGCAGGATGACGCCGACGGGCCGGCTGAGCCGCCCCGAGGAGATCGCCGCCGCCGTGACGTTCCTGGGCTCCGCGGCCAACGGCAACATCTCGGGACAGGTACTCACCGTGGCGGGCGGCCGCTGA	MDMGLGDRTVLVTGGSKGIGLAVARAYSAEGARVALTYRSDEEAAARAAAELGAADGRACHLRYALDEPGSPETVVDEVCARWGGLDVLVANALVRPRRRTPNERFEDLPPAEWEPLLSGNVAGTVRTTQLALARMRKQGWGRIVFVSSHVAVDGKPRQEIYGAAKMALHGLMRSMAWDAGRDGVLVNVVSPGLTLTEGVRTVLPGEVREEERRMTPTGRLSRPEEIAAAVTFLGSAANGNISGQVLTVAGGR	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	94.05	gnl|BL_ORD_ID|2013|hsp_num:0	1574		
BGC0001439.1|Cervimycin_8 # 8274 # 9608 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=CCCC;rbs_spacer=13bp;gc_cont=0.739	BGC0001439.1|Cervimycin_8 	8274	9608	+	Loose	700	53.1434	oleI	31.54	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGATCTTGCGCGTACTGCTCACCACGTGGGCATGGCCGTCACATCTGTTCCCCATGGTTCCGCTCGGCTGGGCCCTTCAGGCCGCGGGACACGAGGTGCGGGTCGCCGTCGGTCCCGGGCTGACCGACGCCGTGAGCCGGGCCGGCCTGTGCCCGGTAACCGTCCGGGACGACGCCGACCTCGTCGGCATGTCCACGGCGCCCGCGCTGAACTCCTGGCACCACCAGCAGCGCTGGACGTCCGACTGGTACGACCGGCCCGAGCTGCTCAGTCCGGCACAGCGCGAGATGTACACCGCCCTGGGGCACAAGCAGACGGCCATGGCCGCGGCCATGGTGGACGGCGTGCTGGACTTCGCCCGCGAGTGGCGGCCCGACCTCGTCGTGCACGACGCGGTCACCTTCGCCGGACTCGTGGCCGGCGCCGTGCTCGGCGTACCGACCGCGGCCACCCTGTGGGGCAACATCGCGATCCCGCGGCACCAGCGGGACCCGCTCACCGGGGAGCTCGCGGCGGACTTCACCGCTCTCTTCGAACGGTTCGGTGTGGCGCCGAAACCCGAACCGGACCTGTGGATCGACCCGTGCCCGCCCCGGATGGGCCTCCCCTCGCCCGAGCCCCGGCTCACCACCCGCTTCGTGCCCTACAACGGCCCCGGCGGCTGCCCCGACTGGCTGCGTGTTCCGGCCGGACGCCGACGCGTCTGCGTCACCTGGGGCATCACGACGGGACGCATCCAGGCGGACGGCGACACCGGCATCTTCGACCAGGTGGCCGAGGCGGTGTCCGGTCTGGACGCGGAGGTCGTCTTCGCGCTCTCGGCCGCGCAGCGCGACCGCCTGGGCGCCGCCACCGCGGACGTACGCGTCGTGGAGGCACTCCCGCTCCATCTGCTGCTGCCGTCCTGCGCGGCGGTGGTCCACCAGGGCGGCGGCGGGACCACCATGACCGCCGTCTGGTCCGGCACTCCGCAGCTGATCGTCTCGCCCCGCCCCGAGCAGATGATGACCGGCGACCGGCTGGAGCGACTGGGGGCCGCACGCCATCTCCTGCGGTCCGAACTGACCGCGGATCCCGCGGCCGGCACCAAGGCGCTGCGCGGCGCGCTCCTGGACCTGCTCGACGACGCCGCGTACGCCCGGGGCGCCGCCGAACTGCGCGACGAGCAACGCGCCCAGCCGAGCCCGGCCGATCACGTGCGGCGGCTCGAGGAGCTGGCGGCGTCCGGCGGCTCGGGCGGGCCTGGGAGGGCGGGCAGCCGACCTCCGTCACCGGCACGTCGGGAGAACGCCCCGTCGCCCGCCACCAGTACGTCCGCGAGAGGACTCGGATGA	MILRVLLTTWAWPSHLFPMVPLGWALQAAGHEVRVAVGPGLTDAVSRAGLCPVTVRDDADLVGMSTAPALNSWHHQQRWTSDWYDRPELLSPAQREMYTALGHKQTAMAAAMVDGVLDFAREWRPDLVVHDAVTFAGLVAGAVLGVPTAATLWGNIAIPRHQRDPLTGELAADFTALFERFGVAPKPEPDLWIDPCPPRMGLPSPEPRLTTRFVPYNGPGGCPDWLRVPAGRRRVCVTWGITTGRIQADGDTGIFDQVAEAVSGLDAEVVFALSAAQRDRLGAATADVRVVEALPLHLLLPSCAAVVHQGGGGTTMTAVWSGTPQLIVSPRPEQMMTGDRLERLGAARHLLRSELTADPAAGTKALRGALLDLLDDAAYARGAAELRDEQRAQPSPADHVRRLEELAASGGSGGPGRAGSRPPSPARRENAPSPATSTSARGLG	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	104.72	gnl|BL_ORD_ID|1723|hsp_num:0	1824		
BGC0001439.1|Cervimycin_9 # 9605 # 10744 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=CCG;rbs_spacer=13bp;gc_cont=0.739	BGC0001439.1|Cervimycin_9 	9605	10744	+	Loose	2000	27.335	Staphylococcus aureus mupB conferring resistance to mupirocin	35.0	3000510	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGACCGCCGCCGCACACACCGCCCCCCTGGACGCCGGCCCCGCCCCGCGGACGGCCGAACTCGGGACCGTCGCGGCACGGTTCGCCGAACGGACCGAGCAAGCGCGCCGGCTGCCCGACGAGGTCGTCGAGGCGCTGCGGGCCGCGGGCTTCGCCCGCCATCTCGTACCCGCCCGGTGGGGCGGCACGGAAGGGACCTTCGGCACCCTGCTCCGTGCCGTCGCCGAGGTCGGCGAGAGCTGTGCCTCGACCGCCTGGAACGCGGCGGTGCACGCCATCCTCGGCCGCATGGTCTCCCATCTGCCCGAGCCGGGGCGGCAGGAGATCTGGGGCGGGGGACCCGACGAACTGTTCGCGGGATCCATCGCGCCGTCCGGTGCGGTGACGCAGGCCGACGGAGGCCACCGGCTCAGCGGCCGGTGGGCCTTCGCGAGCGGCGTCGACCACGCCTCCTGGACCCTGCTCGGCGCCATGGCACCCGGCCCGGAGTACCGGTTCTTCATGGTTCCCCGCACGCACTACCGGATCCTGGACACCTGGGCCAACGTCGGTCTGTGCGGCACCGGAAGCAACGCGGTGGTCCTGGACGACGTGTTCGTGCCCGATCACCTGTCGTTCCCCCAGGCCGAGTTGATGAACGGCGCCGGGGCGCAGGAGGCGGCCCGCACGCGCGTCCCCTTCAAACTCGTCAACGGTCTGACCTTCGTCGCGCCCGTGCTCGGCGCGGCGCGCGGGGCACTGCGGTCGTCGGCGGCACGGCTGGCGGCCAAGACGGAGATCACCGGAAAACCGGCGCGGGCCAACCCGGCGGTCCATACGGCGCTGGCGCGGGCCGGAGCCGAGATCGACGCCGCGCAGTTGCTGCTGGAGCGCGCGGCGGAGGCCGCCGACAGCGGGACGGCCGGCGCCTTCGAACGGGTCCGCTCGCCCAGGGACTTCGCCTTCGCGGCGGAGCTGCTCGGTGGAGCGGTCGACCGGCTCTTCCGCATCGGGGGCGCACGGTCGCAGACCGCGTCCGACCCGGTCCAGCGCGCCTGGCGGGACGTGAACTGCGCGGTGGGCCACGCGGTCCTCCAGTTCGGTTCCGTCGCCGGTGCCTTCACCACCCACCTCATGGACGGAGTGCCCAAGGATGTCTGA	MTAAAHTAPLDAGPAPRTAELGTVAARFAERTEQARRLPDEVVEALRAAGFARHLVPARWGGTEGTFGTLLRAVAEVGESCASTAWNAAVHAILGRMVSHLPEPGRQEIWGGGPDELFAGSIAPSGAVTQADGGHRLSGRWAFASGVDHASWTLLGAMAPGPEYRFFMVPRTHYRILDTWANVGLCGTGSNAVVLDDVFVPDHLSFPQAELMNGAGAQEAARTRVPFKLVNGLTFVAPVLGAARGALRSSAARLAAKTEITGKPARANPAVHTALARAGAEIDAAQLLLERAAEAADSGTAGAFERVRSPRDFAFAAELLGGAVDRLFRIGGARSQTASDPVQRAWRDVNCAVGHAVLQFGSVAGAFTTHLMDGVPKDV	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	36.69	gnl|BL_ORD_ID|2124|hsp_num:0	2271		
BGC0001439.1|Cervimycin_10 # 10737 # 11792 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0001439.1|Cervimycin_10 	10737	11792	+	Loose	500	35.039	chrB	26.92	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGTCTGAGCCGACCCCCGTGGAGCTGCTGACGCCCGCCGGCGGAGTACCGCTGGCCCCCCGGGAGAAGCTGATGCTGCTGGCCAACGGACAGCGGTTCACCGCGGTCATCCACACGTTGGCCGAACTCGACGTCGCCGGACAGCTGGCCGGGGGACCGCGGCACGTACGGGACATCGCCGAAACGGCCGGGTGCCAGGCCACCCCGCTCTACCGGCTGCTCCGGTTCGCCGTGCTCATCGGCCTGTTCCAGGAGACCGAGCCGGAGGTCTTCGCCCTGACCGAACTGGCCGAGGGGCTGCGCGGCGACCTTCCGGACAATGTCCGCGACGCGGTGCTGCTGGACGGCTCGGAGCGGTTCAACCGCGCGTTCACCGGAATCGGGCACAGCGTCCGCACCGGGAAGCCGGGCTTCGACCATGTGCACGGCATGTCGTTCTGGGAGTACCTGGAGCAGGACACACAGGCGCTGCACACCTTCGACGCGGCGATGACCGGGATCAGCCGCCGCCTCGGCCGGCACTATCTGGAGCGCCACGACTTCGGCAGGCCGTCCCGGATCGCCGACGTCGGCGGCGGGCGCGGCTACTTCCTGGCGTCGCTGCTGAAGCGGTATCCGGAGGCGACCGGTGTGCTCTTCGACCGGCCGTCGGTGGTGACCGAGGCGCACGCGCTGCTCCGTGAGCGCGCGGTCGCCGACCGGGTCGACGTCGTCGGCGGCGACTTCTTCACCGACGACCTTCCCACCGGCTGCGACACCTATGTGCTCAAGACGGTCCTGCACGACTGGCCCGACGACGCGGCGGAGACCATTCTGCGCCGGGTCCGCGCCGCCGTCGGTGACTCCGGCGCGCGGCTGCTGATCCTGGAACAGGTGGTGGCGCCGATGAACACCTGGGACCCGGCGAAGTTTCTGGACATCGACATGATGGTGATCATGGGCGGCAGGGAACGCAATCTCCAGGAGTGGCGGCGGCTGCTGGCGGCCACGGGCTTCCGGCTCACCGGGGAACCGGCGACGGGGGAGTGGACCGTGCTGGAGTGCGTGGCCGCGTAG	MSEPTPVELLTPAGGVPLAPREKLMLLANGQRFTAVIHTLAELDVAGQLAGGPRHVRDIAETAGCQATPLYRLLRFAVLIGLFQETEPEVFALTELAEGLRGDLPDNVRDAVLLDGSERFNRAFTGIGHSVRTGKPGFDHVHGMSFWEYLEQDTQALHTFDAAMTGISRRLGRHYLERHDFGRPSRIADVGGGRGYFLASLLKRYPEATGVLFDRPSVVTEAHALLRERAVADRVDVVGGDFFTDDLPTGCDTYVLKTVLHDWPDDAAETILRRVRAAVGDSGARLLILEQVVAPMNTWDPAKFLDIDMMVIMGGRERNLQEWRRLLAATGFRLTGEPATGEWTVLECVAA	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	125.36	gnl|BL_ORD_ID|284|hsp_num:0	305		
BGC0001439.1|Cervimycin_11 # 11920 # 13137 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=CGA;rbs_spacer=15bp;gc_cont=0.741	BGC0001439.1|Cervimycin_11 	11920	13137	-	Loose	700	56.225	oleI	25.24	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGCGTACTGTTCGCCACTTGGACGGGATCCTCGCACCTGTTCCCGATGGTTCCGCTGGCCTGGGCCGCACGGGCGGCCGGGCACGAGGTACGGATCGCGGCACCGCCCTCCTGCACGGAGTCGGTCGGCGGTGCCGGGCTGACGGCGGTACCGGTGGGCCGGGACGTCTCGGGCGAGGAGATGGCCCGGCGCACCGAGGGGCTCGGCGCCTGGCTGGGCGAGACGGCGCCGTGGCCGCGGGACTGGGCGCGCTCGCCGGAGACACAGGGCCCCGAGGTCGCCGCCGTGTACACCGCCCTGGCGGAGAAGCAGCTCGTGGTCGCCGACGCGCTGGTCGACGACCTGCTCGCCTTCGCCAGGGCCTGGCGCCCGGACGTCATCGTGCACGACACCGTGTGCTACGCCGCGGCCGTGGTGGGCGCGGTACTCGGCCTCCCTACGTTCAGTCACATGTTCGGCTCTCCGATGATCACCCGCAACGAACTGGAGGGCATGACGGGCGACCCGCTGCCGGGCTACACGGCCCTGTTCGAGCGGTTCGGCGCCCGGCCCCCGGAGGGTCCCACGGGGTGGATCGATCCCTGTCCTCCGCAGCTTCAGTGGCCGGCCGCCGTGGAGCGCACATCCGTCCGTTTCGTGCCGTACAACGGCAGCGGCGGAGTGGAGCCGACGTGGCTGCGCGAACCTCACAGCAGGCCGCGGGTCTGCCTCACCTGGGGGGTGACCGCCGCCCAGGTCCGCCCGGAACGGATGCCGCCGACCTTCGAACGCACCCTCAAGGTGCTCTCCGCACTGGACGCGGAGGTCGTCCTCGCCGTCGGTGCCGCCCACCGGGAGCTGCTCGGCGATCTGCCGCCGGGCGTCCGTGTGGCCGAGTCCGTGCCGCTGTCGCTCCTGCTGCCGGGCTGCGACGCACTGATCCACCACGGTGGTACGGGCACCGGGCTGACCGCGCTGGCGGCCGGGGTGCCGCAGCTCATGTTCCCGCTCGCGCCGGTGCTGGCCGCCTTCGCGGAACGGGTCGACGCGGCGGGCGCCGGCGTCATGCTCGACCCCGCGGACAGCAGCGACGTGGAGGGGATCGAGGCGGCGCTGCGCACCCTGCTGTCGGAGGCGGGCCGCACACGGACCACCGCCGTCCGTACGGCGATGGAAGCCCTGCCCTCCCCGGCCGGCCTGGTTCCGCTCCTCGAGCGGGCGGCCGGCGGCCGTTGA	MRVLFATWTGSSHLFPMVPLAWAARAAGHEVRIAAPPSCTESVGGAGLTAVPVGRDVSGEEMARRTEGLGAWLGETAPWPRDWARSPETQGPEVAAVYTALAEKQLVVADALVDDLLAFARAWRPDVIVHDTVCYAAAVVGAVLGLPTFSHMFGSPMITRNELEGMTGDPLPGYTALFERFGARPPEGPTGWIDPCPPQLQWPAAVERTSVRFVPYNGSGGVEPTWLREPHSRPRVCLTWGVTAAQVRPERMPPTFERTLKVLSALDAEVVLAVGAAHRELLGDLPPGVRVAESVPLSLLLPGCDALIHHGGTGTGLTALAAGVPQLMFPLAPVLAAFAERVDAAGAGVMLDPADSSDVEGIEAALRTLLSEAGRTRTTAVRTAMEALPSPAGLVPLLERAAGGR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	95.52	gnl|BL_ORD_ID|1723|hsp_num:0	1824		
BGC0001439.1|Cervimycin_12 # 13241 # 14248 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.752	BGC0001439.1|Cervimycin_12 	13241	14248	-	Loose	1200	33.113	arnA	36.96	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGTTCGGCAGCGCCGAGGACCAGTACGTCACGCCGGGTGGCTCCGGTCGCGCCAGAGTGGTCGTGCTGGGCGGAACGGGTTTCGTCGGAAGGCATGTGTGCGCCGCACTCCTGAGCGAGGGCGAGGGCGAGGGCAAGGGCAAGGGCCCGGACGTGGTCGCCGTGTCACGGCGGCCCGGGCCGCCCCCCTCCGGCCCGCGCCCGCTCGCACTCGACCTGTGCAGGACCCCGCCGGCCGAGCTGGCGGACGCGCTCACCGGGGACCGGCCCACGCTGGTGGTGAACGCCGCCGGCGCGGTGTGGGCGGCCACCGAGGAGCACATGGTCGCCGCCAACACCGAACTGGTACGGCGGCTGGTCGACGCGCTGCGCCGCGCCAGGCGGCCGGTCCGGCTGGTCCACCTCGGCTCGGTGAACGAGTACACGCCGTCGGCGGACGGGCGGCCGGTCGACGAAGGGACGCCGACCCGGCCCACCACCGCATACGGGCGGACCAAGCTGGCGGGCACCGAGCTGGTGCTGGAAGCGGCGCGGCGCGGAGACATCGACGCGCTCGTGCTGCGGATGGCGAACGTCGCCGGACCCGGCTCACCTCCCGCCAGCCTGCTGGGCCGGGTGGCCCACCAGCTCCGCCTGGCGTGCGCCGAAGGGCGGACCGCCGAGATCCGGCTCAAACCGCTGCGCGCCGAGCGGGACTTCATCGACGCCCAGGACGCCGTCGGCGCCGTGCTCACCGCCGCCCGCTCCGACGTGGGCGGACGGGTACTCAACATCGGCAGCGGCGAGGCCGTCCCGGTGCGCTCGCTGGTCGACCTGCTGATCAAGGTGAGCGGGGTGGCGGCTCACGTCGTCGAAGAGCCGGAGCAGGGCGCCGGGGACGGGCCGCCGGAGCGGCTGGAGGTGGACATCCGGCTGGCCCGCGAGCTTCTGGGCTGGACGCCGCGGCGCCGTCTGGAGGACGCCGTGGCCGATCAATGGCGCGATCTCTCCGAGGCGTCGGGGCACTGA	MFGSAEDQYVTPGGSGRARVVVLGGTGFVGRHVCAALLSEGEGEGKGKGPDVVAVSRRPGPPPSGPRPLALDLCRTPPAELADALTGDRPTLVVNAAGAVWAATEEHMVAANTELVRRLVDALRRARRPVRLVHLGSVNEYTPSADGRPVDEGTPTRPTTAYGRTKLAGTELVLEAARRGDIDALVLRMANVAGPGSPPASLLGRVAHQLRLACAEGRTAEIRLKPLRAERDFIDAQDAVGAVLTAARSDVGGRVLNIGSGEAVPVRSLVDLLIKVSGVAAHVVEEPEQGAGDGPPERLEVDIRLARELLGWTPRRRLEDAVADQWRDLSEASGH	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	50.60	gnl|BL_ORD_ID|1549|hsp_num:0	1643		
BGC0001439.1|Cervimycin_14 # 15043 # 18363 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=CGA;rbs_spacer=14bp;gc_cont=0.754	BGC0001439.1|Cervimycin_14 	15043	18363	+	Loose	500	30.8018	CTX-M-114	29.89	3001974	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	GTGCCGGAACCGGCCCCTTGCCCACCGGGCGTCCGCCGCGGTCCGGCCGGCCTGCACAATCATCCTGTGGTGAGCAGCGTACGCATCAACATTCTGGGCGGACTCGAGGTCTGGACCGACGACGGCACCCCGGTCGGCGTGCCGGGGACACGGCTGCGCGCACTGGTCGTGCTGCTCGCCCTGGCGGCCGGCCGGCCGGTCCCCAGCGAGCGGCTGATCGGCGAACTCTGGGACGAGGAGGACCGGCCCGCGGGAGCGCCGAACGCACTCCAGGTGCTGGTCTCGCGGCTGCGCCGGACGCTGCCGGAGGGCCTCGTCGAGTCCCGGCCCCGCGCCTACCGGCTCGCCGTCCCGCCGCAGGCCCTCGACGCACGGCGGTTCGAGGAACTGGCGGCCCGCGGCCGGGCGCTGGTCGGCGACGACGACGCCGAGGCCTCGGCCGTCCTGCGCGGCGCCCTCGACCTGTGGCGCGGAGAGGCCCTGGAGGACTTCGGGGAGGCCGCGTTCGCCCGGCTGCACCGCAACCGGCTCACCGAGCTGAGGCTCGTCGTCACCGAGGACCGCGTCGAAGCCGACCTCGCCGCGGGAGCCGGGCCCGATCTGGTGCCCGAGCTGGAGACGCTCGTGGCCGTCCATCCGCTCAGGGAACGCATGCGCGCCCAGCTCATGCGGTCCCTGTCCGCAGCGGGGCGGCAGGCCGACGCCCTGGCCGTGTACGAGGAGGCCCGCCGCCTGCTCGCCCGGGAGCTGGGCGTTGATCCGGGACAGGACCTGGCCGAGGCGCACCTCGCGGTGGTGCGCGGCCAGACCGAGCCGGTACGGCACCGGGCCGCGGCACCCGCGGGCCGCCCGCGGACGAACCTGCGGGCCCAGGTCAGCCGGTTCGTGGGCCGGGAGCAGGAGATGGCGGAGATCGGCCGGCTGTTCGGCCGGTCCCGGCTGCTCACCCTGGTGGGACCGGGCGGTGCGGGCAAGACACGGCTCGCCGCGGAGTCGGCGGCCCGGCTGACCCAGGACATGCCCGACGGGACCTGGCTGGTCGAACTGGCCTCGGTGATCGACTCCTCGGACGTGCCCCGGACGGTCGTCACGACGCTGGGGCTCCGGGCCGGCGGACTGATCGCGGGCCCGGTCGGCGGCGCGAGCGACCCCGTCGGACGGCTGACCCAGGCCCTGCGGGACAAGCGGCTGCTGCTGGTGCTGGACAACTGCGAGCAGGTCGTCGACAGCGTCGCCGCACTGGTCGACGCGCTGCTGGCCGAGTGTCCGCGGCTGCGGGTCCTGGCGACCAGCAGGGAACCGCTCGGCATCGTGGGCGAGCAGCTGATCCAGGTGCTTCCGCTGCCCCTGCCGGACCGGACGACGCTCCCCGAAGCCGTCCTGGCCAGCCCGGTGATCCAGCTCTTCGGCGAGCGCGCGGCGGCCGGCCGGCCGTCGTTCCGGGTCACCCGGGAGAACGTCGCGGTGGTCCTCGACATCTGCCGGGCCCTGGACGGCCTGCCGCTGGCGATCGAACTGGCCGCGACCCGTATCCGTTCGATGTCGCTGGAGCAGATCCGCTCCCGCCTCGACGACCGGTTCGTCCTGCTGTCCGCGGGCAGCAGGACGGCGCTGCCCCGCCAGCGGACGCTGCACGCCGTCGTCGACTGGAGCTGGGACCTGCTCAGCACGGGGGAACGCGAACTGGCCGCCCGGTTCGCGGTGTTCCGCAGCGGCGCGTTCCTCGGCGCGGTGGAGCGGGTGGCCGCCGACGACCGGGACGCCCGGTCGCCGCTGGTCCGCGGCCACGAGGTGTTCGAACTGCTGGCAGGGCTGGTCGACAAGTCGTTCCTGACCGTCACCGAGGTGGACGGCGAACCGCGCTACCGCATGCTGGAGACGGTCCGGCTGTTCGCCCTGGCCAAACTCCGGGCCACGGACCGGCCCGAGTGGACGCAGAGCCGCCACGCCGAGTACTTCCTCGCGGTCGCGGAGGAGGCCGAACCGCATCTGCGACGGCACGAGCAGATCGCCTGGCTGCGGCGCCTGACCTGTGAGCACGACGAGTTCTCGGCCGCGCTGAACTGGGCGGTGGAACACGACCGGGGCGAGATCGCCATCCGGCTGGTCGCCGCGCTCGGCTGGTACTGGTTCCTGCACGGCTACCGGCGGGAGGGGGTGCACTGGGCCGAGCGTGCCCTGGCCCTCGATCCCGCCGGGGCGCCGCCGGCCGCACGGGCCCTCGCGCTCCTGACCGCCGTGCCCCAGCTGGCCGGGGAGGGCGGTGAGCCCGAGAGCCTGCGGGCCCGCATCGCCGAGGCGCACGAACTGATCGATGAGCTGGAGCGGGCGGGTACGCCCTTCTCGCACCCCGCGCTCGGTCTGTTCGAGCCCATCGCCGGCATGCTGAGCGGTGACGGCTCCGTCCTGGAGTCGGTCAGACGCCGTTCGCAGGACGCCGATCCCTGGGTACGCGCCCTCGCCCATCTGCACCGGGGACAGATCGAGATGACGCTCGGCGAGGCCGAGAGGGCGGCGGCGGACTACGCGATCGCGGCGGAGCTGTTCCGCGGCGTCGGCGAGCGGTGGGGCACCGCGCAGGTGCTGGTGGCGTCGGCCGAGTCGCAGAGCGCGCGCGGCGACCGGCGTGCGGCGATCGCCGCGCTGGAGGAGGCGCTCCGGCTCGTCGCCGAGCTGGGCGACCGGGAGGATCAGCCGCTGCTGATGGTCCGGCTGGCCACCGAGCGGGCCCACGAGGGCGACCTGGGGCCGGCCGAGGCCGAACTGCGCCGGGCACTCGAGCTGGCGGACGAGCTCGGGTCACGGGAGCAACGCGCCTATGCCCACCAGGCGTTGAGCGACGTCGCCCGTTGGTCGGGGCGCACGGACCGGGCACGGCAGCTGCTCGAAGGGGCGCTCGCCGAGTTCGCGGAGACCGGGCAGCGCCCCGACCAGGTACGTGCCCTGCTCCTTGCCTCCCTGGGCTCGGTCGAGGCCGCCGAGGGCCGGCCGCGGGGTGCCCGCCGGCGATTCGCCGAAGCGGTCACGGCACTGCCGACGGCCCCGGAGCCCGGCATCGCCGCCCGGCTGGCCGAGCTCCTCGCGGAGGTGGAGCTGGCCGAGGGCCGCCCCGAACAGGCGGCGTACATCCTGGGCACGGCGGCCGCCGTGCGCTCCGGGTCCCGGGACGCCGGCCCCGACGCGATCCGTGTCGCCGAGGCCGTGCGCCGCCTGCTGGGCGAGGGTGCGTACGGTGCCGCGCACCGTCGTGGCGCGGTGACGGGCCGGCGGGCCGCGGTCGCCCTTCTGGTGTCGGCCGCGTGCGAGGACCGCGAGCCCTGA	MPEPAPCPPGVRRGPAGLHNHPVVSSVRINILGGLEVWTDDGTPVGVPGTRLRALVVLLALAAGRPVPSERLIGELWDEEDRPAGAPNALQVLVSRLRRTLPEGLVESRPRAYRLAVPPQALDARRFEELAARGRALVGDDDAEASAVLRGALDLWRGEALEDFGEAAFARLHRNRLTELRLVVTEDRVEADLAAGAGPDLVPELETLVAVHPLRERMRAQLMRSLSAAGRQADALAVYEEARRLLARELGVDPGQDLAEAHLAVVRGQTEPVRHRAAAPAGRPRTNLRAQVSRFVGREQEMAEIGRLFGRSRLLTLVGPGGAGKTRLAAESAARLTQDMPDGTWLVELASVIDSSDVPRTVVTTLGLRAGGLIAGPVGGASDPVGRLTQALRDKRLLLVLDNCEQVVDSVAALVDALLAECPRLRVLATSREPLGIVGEQLIQVLPLPLPDRTTLPEAVLASPVIQLFGERAAAGRPSFRVTRENVAVVLDICRALDGLPLAIELAATRIRSMSLEQIRSRLDDRFVLLSAGSRTALPRQRTLHAVVDWSWDLLSTGERELAARFAVFRSGAFLGAVERVAADDRDARSPLVRGHEVFELLAGLVDKSFLTVTEVDGEPRYRMLETVRLFALAKLRATDRPEWTQSRHAEYFLAVAEEAEPHLRRHEQIAWLRRLTCEHDEFSAALNWAVEHDRGEIAIRLVAALGWYWFLHGYRREGVHWAERALALDPAGAPPAARALALLTAVPQLAGEGGEPESLRARIAEAHELIDELERAGTPFSHPALGLFEPIAGMLSGDGSVLESVRRRSQDADPWVRALAHLHRGQIEMTLGEAERAAADYAIAAELFRGVGERWGTAQVLVASAESQSARGDRRAAIAALEEALRLVAELGDREDQPLLMVRLATERAHEGDLGPAEAELRRALELADELGSREQRAYAHQALSDVARWSGRTDRARQLLEGALAEFAETGQRPDQVRALLLASLGSVEAAEGRPRGARRRFAEAVTALPTAPEPGIAARLAELLAEVELAEGRPEQAAYILGTAAAVRSGSRDAGPDAIRVAEAVRRLLGEGAYGAAHRRGAVTGRRAAVALLVSAACEDREP	MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKAMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	380.07	gnl|BL_ORD_ID|993|hsp_num:0	1057		
BGC0001439.1|Cervimycin_15 # 18388 # 19584 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.764	BGC0001439.1|Cervimycin_15 	18388	19584	-	Loose	700	59.3066	oleI	26.09	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGGGTGCTGTTCGCGGCCGTTTCGGTGACCAGCCATCTCCTGCCGATGGTGCCGCTGGCCGGAGCACTGCGCGCGGCCGGCCACGAGGTCCTCCTGGCGGGCCAGCCCGATCTGCTGCCCGAGGCCGAGGCCGCGGGGTTCGTCACCGCCGCCGTGGGCAGCGCGCGGCTGGAGGAGGATCGGCGACGCCGGATGGCCCGAGTGGCGCAGCAGCAGGCGGCCCTTCCCGGCGGAACCTGGCAGCCGACCTGGGACCAGCTCGCCGCACGCTGGCGCGAGCGGGTCGACGGTGTGCTCGGCGACCACCTCGAGATCGGGCGGTGGTGGCGCCCCGATCTGATCGTGACGGACCCCCTGGAGTTCAGCGCGCGCATCCTCGGCGGAGCACTCGGCGTACCCGTGGTGGTGCACCGCTGGGGACCGGAGACCATGTCCACCGAGGCGGCCGAACCGGCCCGGCGGGCGCTGGCGGACCTCTGTGAGCGCGCCGGTGTCCCCGCCGGCCTCGGTGATCCGGCGCTGGTGATCGACCCCTGCCCGCCCGGCTTGCAGTTCCCCGAGGCGGCGCCGGCCCGGGCGGTGCGGCACGTGCCGTTCAACGGCGCCGGCTCCGTGCCGGACTGGGCGCGCCGGGCCACCGGTGATCGGCGCCGCGTCTGTGTGTCCCTCGGGAGCATGCCCGCCCACCTCGGCGGTCTGTCCCTGCTGCGTACCGTCGCCTCGGCGGTGGCCGGACTCGACCGGGTCGAGGCGGTCGTCCCCCTCGGGCCGGAGCTGCGCGAACAGGTCGGCGAACTGCCCGACACCGTACGGGTGGTGGACCCGGCACCGCTCCATCTCTTCCTGGACGGCTGCGCCGCCGTGATCCACCACGGCGGTTCCGGCACGGCGCTCACGGCGATCGCCCACGGCCTGCCCCAGCTGGTGCTGCCCCAGTTCAATCCCGCCCTGGCGATGTGCGGGGAGCGGGTGGCGGCGACGGGCGTCGGCCTGAACCTGGCGGCGGACACGCGGCCCGGCCCGGCGGCGGTCGCCACGGCTCTGCGCACCCTCCTCGACGACCCCGGCCCGCGCATCCGCACGGCGGCGGTGCGCCGGGACATGGCCGGCCAGCCGACGCCGGCGGACCTCGTCCCGCACCTCGAGTCCCTGGCGGCCGGCGGCACACGACGGCCGGCGGCAAGGACCGGCTGA	MRVLFAAVSVTSHLLPMVPLAGALRAAGHEVLLAGQPDLLPEAEAAGFVTAAVGSARLEEDRRRRMARVAQQQAALPGGTWQPTWDQLAARWRERVDGVLGDHLEIGRWWRPDLIVTDPLEFSARILGGALGVPVVVHRWGPETMSTEAAEPARRALADLCERAGVPAGLGDPALVIDPCPPGLQFPEAAPARAVRHVPFNGAGSVPDWARRATGDRRRVCVSLGSMPAHLGGLSLLRTVASAVAGLDRVEAVVPLGPELREQVGELPDTVRVVDPAPLHLFLDGCAAVIHHGGSGTALTAIAHGLPQLVLPQFNPALAMCGERVAATGVGLNLAADTRPGPAAVATALRTLLDDPGPRIRTAAVRRDMAGQPTPADLVPHLESLAAGGTRRPAARTG	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	93.87	gnl|BL_ORD_ID|1723|hsp_num:0	1824		
BGC0001439.1|Cervimycin_16 # 19589 # 20737 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=CGA;rbs_spacer=14bp;gc_cont=0.728	BGC0001439.1|Cervimycin_16 	19589	20737	-	Loose	700	50.0618	mgtA	30.23	3000462	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	mgt macrolide glycotransferase	ATGAGTACGCCGGTGTCCACCCACTTCGCGCCGTCGATCCCGCTCGCCTGGGCGCTGCGCGCGGCGGGCCACGAGGTGCTGGTCGCCGGGCAGCCGGACATCGTGGGTACGGCCCACGGGGCCGGACTGTGCACCGCGGTCGTCGGCGAGTACTTCGACGCGCTGGAGCCGCTCACCTCCGGCCTTCCCGACGGCAAGCGGCCGATCGAGGTGGGACGCACCCGGGTGCGGGACGGGCACTGGGAGGCGGTCAACAAGATCTGGCTGATCCACTGCCGCTACATGGTCTCTCAGTACCTGGCGCTGGCCAGGGAGTGGCGGCCCGACCTCATCGTCGCGGACCCGCTGGAGTTCAGCGCGCTCATCGTCGGCGGGGTCCTCGGGATACCGACGGTCAACCGCCGCTGGGGCATCGACCCGGCCGGATTCCCCGGGCAGGAGATGGCCCGCAGGACGATGGGGACCATGCTCGGCCGCCTCGGTCTCGACGGCCTGCCCGAGCCCGCGCTGGTCATCGACCCCTGCCCGCCGAGCCTCCAGGTCCCGGAGGCGCCGCCGAGCCGGGGCATGCGGTACGTGCCCTTCAACGGCAGCGGCACGCTGCCCGACTGGGCGAAGGAGGAGCCGCACGGTCGGCGCCGGGTCTGTGTGACGTTCGGGCGGCTGACCGCGGCGCTGAACGGCATCCCCCTGTTCCGGGCCACCGCCGAGGCCGCCGGGGAGTGCGAGGACGTGGAGACGATCCTGACGCTCGAGCCGGAGTTCCAGGACGAGCTGGGCCCGGTCCCGCCGTCCGTACGGGTGGTGGGCCCGGCCCCGCTCAACCTCTTCCTCGGCACCTGCGACGCGGTCGTGCACCACGGCGGGGCCAGTTCGACGCTCACCGCCTCGGCGTTCGGGCTGCCGCAGCTGGTGCTGCCCGGCATCACCGACACGTTCGTCGTGGCCGACCGTGTCGAGGCCGTCGGCGCGGGCCGCCAGCTCGACGAGGCGGAGACACAGAACGACCCGGCCGCGATCCACGCGGCGCTGCGTGCCCTGCTCGACGAGCCGGGCTACACCAAGAGCGCCCATCAGCTGCGCGACGAGATCGCGTCCATGACGACCCCGGCCGGTCTGGTGCCCGTACTCGAAGAACTGGCGGGCTGA	MSTPVSTHFAPSIPLAWALRAAGHEVLVAGQPDIVGTAHGAGLCTAVVGEYFDALEPLTSGLPDGKRPIEVGRTRVRDGHWEAVNKIWLIHCRYMVSQYLALAREWRPDLIVADPLEFSALIVGGVLGIPTVNRRWGIDPAGFPGQEMARRTMGTMLGRLGLDGLPEPALVIDPCPPSLQVPEAPPSRGMRYVPFNGSGTLPDWAKEEPHGRRRVCVTFGRLTAALNGIPLFRATAEAAGECEDVETILTLEPEFQDELGPVPPSVRVVGPAPLNLFLGTCDAVVHHGGASSTLTASAFGLPQLVLPGITDTFVVADRVEAVGAGRQLDEAETQNDPAAIHAALRALLDEPGYTKSAHQLRDEIASMTTPAGLVPVLEELAG	MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPPLLADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEPDLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYARFHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDWARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNVEVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVARTLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEGGTRRAADLIEAELAAARG	91.39	gnl|BL_ORD_ID|2357|hsp_num:0	515		
BGC0001439.1|Cervimycin_17 # 20880 # 21398 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.736	BGC0001439.1|Cervimycin_17 	20880	21398	-	Loose	500	30.8018	APH(3'')-Ia	45.95	3002638	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	ATGCCGGCGGCCCCCGTCGCCCTGCCGGCCGTCGCCCCGGCCGCCGCCGTCACGGCGGTGCGCGCCCACAAGGCCGGGCGCGGCGACATCAGGAACGCGGCCCTCACCCTCCTCGCGGAGCAGCCGGCCAACGGGTACCAGGTCATCCAGTACATCGCCGAGCGCAGCCACGGCTCCTGGCGGCCGAGTCCGGGCGCGGTCTATCCCGCCCTCCAGGGCCTGGAGCAGGACGGGCTCGCCGAACAGGTGGAGGGCTCCGGTCGCAAGAGCTACCGGCTGACCGACGCCGGGCGCGAGCACGTGGCGGAGCACCGTGCCCAGCTCGACACCCTGTGGGACAACCTGGCCGACGCCGTCGACGACCGTGCCGTGGAGATCAACACCCTGTGCGAACACGTCGTCACCGCCGTACGCCACGTGCTGCACGACGCCGACGACGAGCGCTACGACCGGACGCGCCAGGTTCTCCTCGACGCGCGGCGTTCGCTCTACCGGCTGCTCGCCGAGCAGGACGACTGA	MPAAPVALPAVAPAAAVTAVRAHKAGRGDIRNAALTLLAEQPANGYQVIQYIAERSHGSWRPSPGAVYPALQGLEQDGLAEQVEGSGRKSYRLTDAGREHVAEHRAQLDTLWDNLADAVDDRAVEINTLCEHVVTAVRHVLHDADDERYDRTRQVLLDARRSLYRLLAEQDD	MSDHPGPGAVTPELFGVGGDWLAVTAGESGASVFRAADATRYAKCVPAADAAGLEAERDRIAWLSGQGVPGPRVLDWYAGDAGACLVTRAVPGVPADRVGADDLRTAWGAVADAVRRLHEVPVASCPFRRGLDSVVDAARDVVARGAVHPEFLPVEQRLVPPAELLARLTGELARRRDQEAADTVVCHGDLCLPNIVLHPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERARFADAAFAERYGIAPDPERLRFYLHLDPLTWG	63.24	gnl|BL_ORD_ID|1816|hsp_num:0	1923		
BGC0001439.1|Cervimycin_18 # 21499 # 23346 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0001439.1|Cervimycin_18 	21499	23346	+	Loose	900	185.652	otr(B)	31.74	3002892	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGTTCCACCTGTCTGTTCGCTCGAACTTCAGGAATGCCCTGGATGCCATGAAGATATATCTAGAACTTCTATAGAGCAAGCCCGTCCCGCCCGCCGCCCGATGCCGCTCCTCTCGCGGTGCGGCCGTGCGAACGGCCGGCTCAGCTCCGTGTCAGCGCCGGCTCAGGTCGGCGTCGCAGGGTGGTCCCGGACGAGCGGCGCCGTGCCGGGCCGCGCCATCACCGACGAACGAGGAGCATCCACAGAGATGAGCGGTCCGACCACCACGACGGCGAAGCAGACGCCCGACGGGCCGAGGACGATGTCGCCGAGGATGATCAAATGGGTCTCGGCCAGCGCGCTCGGCACCCTGCTGCTGGCCAGCCTCGACCAGACCATCGTCGGCAGCGCCGCCTGGACGATCGCCCGGGACCTGGATCCGCAGCAGGGCCTGCGCATGCTGCCCTGGCTGTTCACCGTCTACCTGCTGGCCTCGACCGCCACCCAGCCGCTCTACGGCAAGCTGAGCGACGTCTTCGGCCCCAAGCGCGTCTTCCTGTTCGCCACCAGCCTGTTCCTGGCCGGTTCGATGCTCTGCGGAACCGCCCAGAGCATGACCCAGCTGATCGTCTTCCGGGGCGTCCAGGGCCTCGGCGCGGGCGGTCTCGTCGGCGTGACACTGGTGATCGTCGCGATGATCTCGCCGCCCAAGGACCGCGCACGCAGGTCCGGCCTCGGCGGCGCGATCATCGGCGGCGGAAGCGTCGCGGGTCCGCTGCTCGGCGGCGTGGTCAGTGAACACCTCTCCTGGCGCGGACTGTTCTACATCAACCTGCCGCTCGGCCTCGCGGCACTGGCGATCATGCTGTACGCGCTCCACCTGCCCGCCGGCCGGCGACGCCGCGAGCCGGTCGACATCCTCGGTGCGGTGCTGATCGCGGCGGCCGCGAGCGTCATCCTGCTGGTCACGGACTGGGGCGGCACGAAGTACGCGTGGAACTCGCCGCTGATCCTCGTCATGGGCCTCGGCGGCGTCCTGCTGACCGCCCTGTTCATCTGGTGGGAACGGCGCACGCCGGCACCGATCCTGCCGCTGTCGCTGTTCCGCAACCCGGTCTACCGCACGGTCACCCCGCTGCAAATCGTCACGGGGCTCGCCGTCATGTCCGCGCCCGTCTACCTGGCCACGTACATGCAGATCGCGCAGGCGCACACGCCCACCAGCTCGTCCCTGTTCACCGTGCCCCTGGCGGTCGGCCTGGTGCTCTTCTCGACCTCCGGCGGCATGTGGATCTCCCGGTTCGGCCGCTACCGCATGGTGCTGGTGCTCGGAAACGTGCTGTGCACGCTGGCCCTCGCGCTCCTGGGCACCCTCGGCACACACACTCCGTCGTGGGTGATCGCGGTCGATCTGTTCCTGCTCGGCTCGGGGCTCGGCGGACTCATGCAGGTGTCGGTCCTCGCGGTGCAGAACTCCGTCGAGGCCCACCAACTCGGCGTGGCCACCACCTCGGTGCGGTTCATGGGCCGGATGGGACAGGCACTGGGCACCGCCCTGCTCGGCGTCCTGCTCAACTCGGCCTTCAACTCCCGGCTGCCGCAGGAGGTGCGGGACCAACTCGGCGGGAACGTGTCGAACCTCGGGTCCGTCCAGCAACTGCCCGAGGCGGTGCGGGAGACGGTCGTGGACGCGTTCGTCTCGGCCAACCGGGTCATGTACCTCTCGGCGGCCGCCGTCTCGGTGATCGCCGTCGCGCTCTCCTTCCTCGTGAAGGAGACGATGCACAGCGCGGAGCCGAACTGGGCCGAGGCGAAACCCGACCCCGGCGCGGGCAAGGCCGAGGGGACCGGCTCCGGGGAAGCCTGA	MVPPVCSLELQECPGCHEDISRTSIEQARPARRPMPLLSRCGRANGRLSSVSAPAQVGVAGWSRTSGAVPGRAITDERGASTEMSGPTTTTAKQTPDGPRTMSPRMIKWVSASALGTLLLASLDQTIVGSAAWTIARDLDPQQGLRMLPWLFTVYLLASTATQPLYGKLSDVFGPKRVFLFATSLFLAGSMLCGTAQSMTQLIVFRGVQGLGAGGLVGVTLVIVAMISPPKDRARRSGLGGAIIGGGSVAGPLLGGVVSEHLSWRGLFYINLPLGLAALAIMLYALHLPAGRRRREPVDILGAVLIAAAASVILLVTDWGGTKYAWNSPLILVMGLGGVLLTALFIWWERRTPAPILPLSLFRNPVYRTVTPLQIVTGLAVMSAPVYLATYMQIAQAHTPTSSSLFTVPLAVGLVLFSTSGGMWISRFGRYRMVLVLGNVLCTLALALLGTLGTHTPSWVIAVDLFLLGSGLGGLMQVSVLAVQNSVEAHQLGVATTSVRFMGRMGQALGTALLGVLLNSAFNSRLPQEVRDQLGGNVSNLGSVQQLPEAVRETVVDAFVSANRVMYLSAAAVSVIAVALSFLVKETMHSAEPNWAEAKPDPGAGKAEGTGSGEA	MSSANPGPAGTADQAGGAFTHRQILTAMSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIYGRKPMYLISIVVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFLAGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA	109.24	gnl|BL_ORD_ID|910|hsp_num:0	870		
BGC0001439.1|Cervimycin_19 # 23529 # 24677 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.765	BGC0001439.1|Cervimycin_19 	23529	24677	-	Loose	700	50.0618	oleD	33.64	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGGTCAGTCCGGTGCCCACGCATCTGGCACCGGTCGTTCCGCTCGCCTGGGCACTGCGTTCCGCGGGGCACGAGGTCCTCGTCGCCTGTCAGCCGGATGTGGTGGTGACGGCACGGCTGGCGGGTTTCGGTGTCGCGGTCGTGGGTGACGCCTACGACGACATCGGCAGGCGCCGACGCGAGGCGCCGCCCGCCGGGGCCGGGGCCGGCGCCGGCCCCGGCTCCGCGGCGGACGCGGGCGGCCCGCCCTGGCCGATGCTGGCGCGCAAGTGGCGCGAGCGGATCGACCGGGTGCTGGGCCCCTACCTGGCCGTGGCCCGGCGCTGGCGGCCGGATCTGATCGTGGCCGATCCGCTGGAGCTGGCGGCGCCTCTGGTCGCCGGTGAACTCGGGATCCGGTACGTCCACCACCGTTGGGGGGTGGACGCGTTCGGCGACGAGCGGTGGGGGCACGCGCGGCGGGCGCTGTCCGAGGTGTCCGGCGCCCGGCCGGGCGACGGTCCGCCCGCGCCCTCGGCGGTGCTCGATCCGTGCCCGCCCCGTCTGCAGGAGCCGGGCCTGAGCCGTGGCGCGGGGATCCGGTTCGTACCGTTCAACGGCAGCGGGAGCCGGCCCGGGCTCGCCCCGCCGCGCGGCGCCCGGATCTGCGTGTGCTTCGGCACCAGGACGGTCGCGCTGGGCGGCGCCGACGTCGTACGGCGAACGCTTCGGGCGCTGACCGGGCCGGGGGCGTCTGCGGAGGTGGTGGTGGCGGGCGCGGACGCCGAGTGGGGTGAACTTCCGGACGGGGTACGGGTCCTGGGGTCGACGCCGCTGCATCTGTTCCTCTCGGAGTGCTCGCTGGTGGTGCACCACGGCGGTGCGGGAACCACGCTCACCGCCACGTCCTTCGGGCTGCCCCAGCTGGTGCTGCCGCAGGCCCCGTATCTGGTCGAGCACGGCCGGCGGCTGGCCGACTGCGGCGCGGGCGCGATGCTGGCCGACGGTGAGCAGGGTGCGGAGGACATCCGCGGCGCCGTCGCGGACCTACTGTCCCGCCCCGGCCCGGCGCGGGCCGCACGCGAACTGGCACGGGAGATGGCCGCGATGCCGGCACCCGGCAGTTGGGTGGCTCCGCTGGAGGAACTCGCGGGCCGCACGGCGGGGTGA	MVSPVPTHLAPVVPLAWALRSAGHEVLVACQPDVVVTARLAGFGVAVVGDAYDDIGRRRREAPPAGAGAGAGPGSAADAGGPPWPMLARKWRERIDRVLGPYLAVARRWRPDLIVADPLELAAPLVAGELGIRYVHHRWGVDAFGDERWGHARRALSEVSGARPGDGPPAPSAVLDPCPPRLQEPGLSRGAGIRFVPFNGSGSRPGLAPPRGARICVCFGTRTVALGGADVVRRTLRALTGPGASAEVVVAGADAEWGELPDGVRVLGSTPLHLFLSECSLVVHHGGAGTTLTATSFGLPQLVLPQAPYLVEHGRRLADCGAGAMLADGEQGAEDIRGAVADLLSRPGPARAARELAREMAAMPAPGSWVAPLEELAGRTAG	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	92.05	gnl|BL_ORD_ID|1284|hsp_num:0	1367		
BGC0001439.1|Cervimycin_20 # 24782 # 25726 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=CCCC;rbs_spacer=14bp;gc_cont=0.671	BGC0001439.1|Cervimycin_20 	24782	25726	+	Loose	725	27.7202	CepS	29.85	3003553	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CepS beta-lactamase	ATGGGCTTCAGTCCGGTGCTCACTCCATCGGAACGGACGGAGAACATGAAAGGGATCATCCTGGCGGGAGGCAGTGGCACGCGGTTGTACCCGACGACGCTCGCGGTCTCCAAGCAACTGATGCCGGTCTACGACAAACCCACCATCTACTACCCGCTCTCGGTGCTCATGCTGTCCGGCATCACCGACATCCTGATCATCTCCACCCCCGCGGACCTCCCGCAGTTCCAGCGACTGCTCGGCGACGGCAGCGAGTGGGGCCTCACGTTCGGCTACGCGGCGCAGGAGCGTCCCAACGGGCTGGCGGAGGCGTTCCTCATCGGCGCGGACCACATCGGCGGCGACTGTGTGGCCCTGGTCCTGGGCGACAACCTCTTCCACGGCCCGGGGCTCTCGCCACTGCTCCAGAAGAACGCACGCGACGTGGACGGCTGCGTCCTGTTCAGCTACCAGGTCAGTGATCCCGAGCGCTACGGCGTCGGCGAGGTCGACGACCACGGACGGCTCGTCTCGATCGAGGAGAAGCCGGCCGTCCCGCGCTCCAACCGTGCCATCACCGGACTCTACTTCTACAGCCACGACGTGGTGGACATCGCCAAGAACATCAGGCCGTCGGAGCGCGGAGAGCTGGAGATCACCGATGTGAACCGTACCTATCTCGCCGAGGGCAGGGCCCGGCTGGTCGAGCTGCGCCGGGGATTCACCTGGCTGGACACCGGTACTCCCGAGGCGCTGCTCACGGCGAGCCAGTTCGTCGGCATCCTGGAGAGCCGGCAGCGGGTTCGGATCGCCTGCCTCGAGGAGATCGCCCTGCGCATGGGCTACATCGACGCGGAGGCCTGTCACCGGCTCGGCGAGCGCCTGGGCACGTCGGACTACGGGCGGTACGTGATGGAAGTCGCCGAGGCGTGGCGACCCTCCTCGGTGACGGCCCGCAGCAGGTGA	MGFSPVLTPSERTENMKGIILAGGSGTRLYPTTLAVSKQLMPVYDKPTIYYPLSVLMLSGITDILIISTPADLPQFQRLLGDGSEWGLTFGYAAQERPNGLAEAFLIGADHIGGDCVALVLGDNLFHGPGLSPLLQKNARDVDGCVLFSYQVSDPERYGVGEVDDHGRLVSIEEKPAVPRSNRAITGLYFYSHDVVDIAKNIRPSERGELEITDVNRTYLAEGRARLVELRRGFTWLDTGTPEALLTASQFVGILESRQRVRIACLEEIALRMGYIDAEACHRLGERLGTSDYGRYVMEVAEAWRPSSVTARSR	MKQTRALPLLALGTLLLAPLSLAAPVDPLKAVVDDAIRPVLKQHRIPGMAVAVLKGGQAHYFNYGLADVATGAKVNEQTLFEIGSVSKTYTATLGAYAVVKGGFKLDDQVSGHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVDSSDTMRAYYRHWTPPYQAGTQRQYSNPSIGLFGHLAASSLQQPFSTLMEQTLLPALGLEHTYLQVPEAAMARYAFGYSKEDKPIRVNPGMLADEAYGIKTGSADLLAFVKANISGVDDKALQQAIALTHTGFYRIGEMSQGLGWESYAYPVSEQTLLAGNSPAVSLKANPVTKFETPAAPGAMRLYNKTGSTGGFGAYVAFVPAKGIGIVMLANRNYPIEARVSAAHAILSQLAP	82.20	gnl|BL_ORD_ID|278|hsp_num:0	299		
BGC0001439.1|Cervimycin_21 # 25736 # 26548 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.652	BGC0001439.1|Cervimycin_21 	25736	26548	-	Loose	470	33.4982	sdiA	31.15	3000826	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCGACCACGTCTGCGTGCCACGCGCATGAGACCAACGGGGGGAAGCCGGTCGTATTCGCCCCTTACCTCTTCATGCGGCGTGCCGGGCCGCGCGGGTACGCTCTCCTATTTCGGTCATATGGATTACAGGAGGGCGAAAGGTTGACACGGGGGAACAGTCGCGTACATCCGACGGCGGCCACGCAGACCATAAGCGTGTTCGTCATGGATGTGAACGCCATATTCAGGGAAGGCCTGCGGACCGTCATAGCCCAGGACGAGGGCCTGAGCGTGGTCGGCCACGGCTCGGACGACGTGTCGGCGATGCTGGAGAGCATCGCCGACACCCGTCCCGACGTGGTCCTGCTGGGCCTGGAACGCATCACCGGTGGCACGGAGTCCGTCGTCGCGGACATCTTCCGCGCGGTACCGCGCACGGAGGTCATCGTGCTGGGGTGGGGCGTGGGGGCGGACCAGCTGGGGCCGCTGATGGCTCAGGGCGTGCGCGCGTATCTGCCCAAGGACGTTCCGCACCGCTACCTGCTCTCGACGATCTACATGAGCACCTTCGAGGACAGCAGGATGGTCTTCTCGTGGCCGCGCTCGGCCGCGGGGAAGCGCGGCGAACTCGCCGCCCTGTCCTCCCGGGAACGCGAGGTGGTCGAGCTCGTCGGCAGAGCCCTGACCAATGCGCAGATAGGGCGTCAACTGCGCATCTCCGAAGGCACGGTGAAACGGCATCTGCACAACATCTTCGTGAAGCTGCAAGCCGTTTCCCGGTTGGACGCCGTCAACAAGGCCGTCGAGCTGTCCCTCATCATGCTCGAGTGA	MSTTSACHAHETNGGKPVVFAPYLFMRRAGPRGYALLFRSYGLQEGERLTRGNSRVHPTAATQTISVFVMDVNAIFREGLRTVIAQDEGLSVVGHGSDDVSAMLESIADTRPDVVLLGLERITGGTESVVADIFRAVPRTEVIVLGWGVGADQLGPLMAQGVRAYLPKDVPHRYLLSTIYMSTFEDSRMVFSWPRSAAGKRGELAALSSREREVVELVGRALTNAQIGRQLRISEGTVKRHLHNIFVKLQAVSRLDAVNKAVELSLIMLE	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	112.50	gnl|BL_ORD_ID|212|hsp_num:0	228		
BGC0001439.1|Cervimycin_22 # 26781 # 27575 # -1 # ID=1_22;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.684	BGC0001439.1|Cervimycin_22 	26781	27575	-	Loose	400	28.1054	vanRM	27.4	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	TTGCAGTTCAAGATTCTCGGCCCGATGGAAGTGCTGCACGACAACACAAAATGCACGCCGACCGCGCCCAAGGCACGGAACACCCTGGCACTCCTGTTGTCCCGCGCCAACCAGATCGTCGAGATACCCGCGCTCATCGACGAACTCTGGAGCGACAATCCGCCGCGCAGCGCCGTCACCACCGCGCAGACGTACATCTACCAACTGCGGAAGATGCTCTGCCGGACGGTCGGGGAGGAGGCGGCCGCCCGCCTCCTGATCACCCAGGCCCCCGGGTACGGGCTCCGCGTCGACGAGAACCGGATCGACGCGCGCGTCTTCGAGCGGTTGACCGCACAGGGCAAGCGCCTGCTGAACACGGGCCGCCCCGAGGAGGCGGCACGCCACCTGCGCGAAGCCCTGGCCTTGTGGCGCGGCCCCGCCCTGGCCGACGTCTGCACGGGAAGCAGACTCGAGGCGCACGTCGTCCAGCTGGAGGAAATGCGCTTGACCGCGCTCCAGTTGCGCGTGCAGGCCGACATCCGGCTGGGCCGGCACGCCGAGCTCGTACCCGAGCTTCGTTCGACGGTGGCGGGCCATCCGCTCAACGAATGGTTCCACGCCCAGCTGATCACGTGCCTGCGCCAGTCCGGGCGCAGGGGCGAAGCCCTCCAGGCCTATCAGTCCCTGCGACGGCTGCTGGACGCCGAGCTGGGACTCCAGCCGTCGCTGCCCCTCCAGCGCCTCCAGCAGCACCTGCTCAGCGACTCGCCGGACGGCGACGTATTCGCCCTCGACTTGAGCGTTTCGGCGTGA	MQFKILGPMEVLHDNTKCTPTAPKARNTLALLLSRANQIVEIPALIDELWSDNPPRSAVTTAQTYIYQLRKMLCRTVGEEAAARLLITQAPGYGLRVDENRIDARVFERLTAQGKRLLNTGRPEEAARHLREALALWRGPALADVCTGSRLEAHVVQLEEMRLTALQLRVQADIRLGRHAELVPELRSTVAGHPLNEWFHAQLITCLRQSGRRGEALQAYQSLRRLLDAELGLQPSLPLQRLQQHLLSDSPDGDVFALDLSVSA	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	113.79	gnl|BL_ORD_ID|709|hsp_num:0	752		
BGC0001439.1|Cervimycin_23 # 27703 # 28749 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=CGA;rbs_spacer=13bp;gc_cont=0.731	BGC0001439.1|Cervimycin_23 	27703	28749	-	Loose	650	26.9498	vanF	31.94	3002908	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	GTGGTGAGCGCGGAAGCCCGGCCCGGGCCCGTCCGCGTGGGCGTACTGGGCTGCGCGGACATCGCGGTACGCCGGATGCTGCCCGCCCTGTCGAGCCAGCCGCTGGTCGACCTCGTCGCGGTCGCCAGCCGCGGCCTCGACAGGGCACGGGAGGTCGCCGGCCGCTTCGGCTGCGAGGCCGTCGAGGGGTACGCACGGCTGCTCGCCCGGCCCGACATCGACGCCGTGTACATCCCGCTCCCGACGGCACTGCACGCCGAGTGGGCCGTCCGGGCCCTGGAGTCGGGCAAGCACGTCCTGTGCGAGAAGCCGTGCGCCACCGGCCCGCGGGAGGCCGCGCAGGTGGTGAGGGCCGCGCGGGAACGCGGGCTGCTGGTGATGGAGAGCTTCATGTTCCTCCATCACCGGCAGCACGCACGCGTGCGCGAACTCGTCCGCGACGGGGCCATCGGCCGGCTTCGCGAGGTCACCGCCGTGTTCGGGATCCCGGCCGCGCCGCGCGGGGCGGCCGGGGAGGGGCACGCCCTCAGCAGCCTGCTGGAGACGGGTGTGTATCCGGTCCGGGCGGCCCGGCTGTTCGCCGGGGACGGTCTGGAGGTCGTCGGCGCCGCACTGACGCTCGACCCGGAGTCCGGACGGGACCTCGCGGGCAGCGCGCTGCTGCGGTCCCCGTCCGGCGTCCACGCGCGACTGGGGTTCGGCTGGGACCGCTTCTACCGGTGTACATACGAACTGTGGGGCAGTGAGGGCAGGCTGACGCTGGAGCGGGCGTTCACCACCCCGGACGCGCACCCTCCGGTCCTGCGGCTGGAACGGCAGTCGTCCGTCGAAGAGCTGACGCTGGCACCGGACCGGCAGTTCGTGAACATCGCCGGCGTCTTCGCCCGCACCGTGGCGAACGGGACGGGGTTCGAGGAGTACACCGATGACATTCTGCGGCAGGCGGCATTGGTGGACCGGATACGCCGGGCGGCGGCCCCCGGCAGCCGGTCCGGTACAGGTGAGCAGTCCCGGCATCGCATACCACTTGAGTTGTATCACCCTTGA	MVSAEARPGPVRVGVLGCADIAVRRMLPALSSQPLVDLVAVASRGLDRAREVAGRFGCEAVEGYARLLARPDIDAVYIPLPTALHAEWAVRALESGKHVLCEKPCATGPREAAQVVRAARERGLLVMESFMFLHHRQHARVRELVRDGAIGRLREVTAVFGIPAAPRGAAGEGHALSSLLETGVYPVRAARLFAGDGLEVVGAALTLDPESGRDLAGSALLRSPSGVHARLGFGWDRFYRCTYELWGSEGRLTLERAFTTPDAHPPVLRLERQSSVEELTLAPDRQFVNIAGVFARTVANGTGFEEYTDDILRQAALVDRIRRAAAPGSRSGTGEQSRHRIPLELYHP	MNRLKIAILFGGCSEEHDVSVKSAKEIANNIDTEKYEPIYIGITRSGVWKMCEKPCMDWDNENCRSAVLSPDKKMHGLLVMRNKGYQIQRIDAVFSVLHGKSGEDGAIQGLFELSSIPYVGCDVQSSAVCMDKSLTYIVAQNAGFGTPEFLILNHGDIPDSNTLTYPVFVKPARSGSSFGVNKVNNEDELDAAIETARQYDSKVLIEQAVPGLEVGCAVLGNGTDLIVGEVDQISLSHGIFRIHQEDQPEKGSENAVVLVPANLSAEKRIKIQETAKAIYKALGCKGLSRVDMFLQENGRIILNEVNTLPGFTAYSRYPRMMAAAGMTLSGLIDHCITLALKG	101.46	gnl|BL_ORD_ID|1658|hsp_num:0	1759		
BGC0001439.1|Cervimycin_24 # 28743 # 30188 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.664	BGC0001439.1|Cervimycin_24 	28743	30188	-	Loose	1900	32.7278	MuxC	36.84	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCCCGCTCGTATCCCTGCCCGAAGCGCTCGCGGCCTCCGGCTCGCCCGGCCTCGGCCGGCGGTTCACCGTCTCGGCGTCCGCGACCGACAGCCCGGTCACTCCGAACGCGGAGTTCGACGCCTGGTTCGCGCGGCACCGAAGAGCAAACCGGTTCAAAGTCACCCGGATCCCCTTCAGTGATCTTGTCGGCTGGCGATTCCGGGAAGGCGACGGGAATCTGGTCCACGACAGCGGAGGATTCTTTTCCGTCACCGGGCTGGAGGTGAACACCGACTGGCAGGACCGCGGCACCTGGTCGCAACCGATACTGGACCAGCCCGAGATCGGCGTACTCGGCATTGTCGTCAAAGAGTTCGACGGCGTACTGCACTGTCTGATGCAGGCGAAGATGGAGCCCGGAAACCCCGAAACCGTCCAGCTCTCACCCACCGTACAGGCGACCCGGAGCAACTACACCGGTGTACACGGTGGGCGCCGCACGGCCTACATCGAGTACTTCACAAGCCCGCGGCGAACGCTGCTGGTCGATTCCCTCCAATCCGAACAAGGTGCCTGGTTTCTGCAGAAGCGGAACCGGAACATGATCGTCGAAGTCACCGGTGACGTTCCGCCGCACGACAACTTCCGCTGGCTCACGATCGGGCAGATACACCGGGTCCTCGGTCAGGACAACGTAGTCAACATGGATACACGCACCATCCTGTCCTGTGTGCCTTTCGAGACACCCGACGGACTCATCCGGAACGAGGTGAACCCCGAGTACCGGGAATCCCTGGCGCGTTCGCTGTCGGGCCGGCACGGCTCGCTGCACAGCACCGGCGAACTCCTGGCCTGGCTGACCGACATCAAGGCACGGCACTCCTTCACCCGGCGCACACTGCCCCTGTCGAAGCTCGACGGCTGGTCGCACTCGGACGACGAGATCGCGCACGACGAGGGCAAGCACTTCAAGGTGATCGCCGCGGATGTGCGGGCCGACACCCGCGAGGTCACCCGGTGGACCCAGCCCCTGATCGCCCCCGTCGAGCGGGGCATCGCGGCCTTCGTGGCCCGGCCCATCGACGGGGTGCTGCATCTGCTGGTGCACGGGAAGGTCGAGTCGGGGAGCTTCGACACGTGCGAGCTGGCGCCCACGGTGCAGTGCCTGCCGGTCAACTACCAGGACCTCCCGGCCCACCGGCAGCCCCGCTATCTGGACCTGGTGCGCGACGCCGCCCCGGACGCGCTGCGCTTCGACGCCGTCCTGTCGGAGGAGGGCGGGCGCTTCCACCACGCGGACAACCGCTACCGGATCGTCGAGGTGGGTGAGGAGGTCCCGCCGCACGACGACCAGGACTACCACTGGATGACGGCCCATCAGCTGATGACGCTGGTGCAGCACAGCCGCTATCTGAACGTGCAGGCGCGAAGCCTGCTGGCGAGTCTGCACACCACGTGGTGA	MPPLVSLPEALAASGSPGLGRRFTVSASATDSPVTPNAEFDAWFARHRRANRFKVTRIPFSDLVGWRFREGDGNLVHDSGGFFSVTGLEVNTDWQDRGTWSQPILDQPEIGVLGIVVKEFDGVLHCLMQAKMEPGNPETVQLSPTVQATRSNYTGVHGGRRTAYIEYFTSPRRTLLVDSLQSEQGAWFLQKRNRNMIVEVTGDVPPHDNFRWLTIGQIHRVLGQDNVVNMDTRTILSCVPFETPDGLIRNEVNPEYRESLARSLSGRHGSLHSTGELLAWLTDIKARHSFTRRTLPLSKLDGWSHSDDEIAHDEGKHFKVIAADVRADTREVTRWTQPLIAPVERGIAAFVARPIDGVLHLLVHGKVESGSFDTCELAPTVQCLPVNYQDLPAHRQPRYLDLVRDAAPDALRFDAVLSEEGGRFHHADNRYRIVEVGEEVPPHDDQDYHWMTAHQLMTLVQHSRYLNVQARSLLASLHTTW	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	46.43	gnl|BL_ORD_ID|2431|hsp_num:0	2720		
BGC0001439.1|Cervimycin_25 # 30220 # 31200 # -1 # ID=1_25;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0001439.1|Cervimycin_25 	30220	31200	-	Loose	1200	38.5058	arnA	23.85	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	TTGGGGGTACATGCGGTGCGTGTTCTGGTCACGGGCGGCGCCGGATTCATCGGCTCGTGCTACGTCCGTGCGCTGCTGGACGGTGCGTACCCGGGCTACGAGGACGCCCAGGTCACCGTCGTGGACAAGCTGACCTACGCGGGCAATCGGGCCAACCTTCCGGAGCGGCACGAGAGGCTGCGGTTCGTGGTCGGCGACATCGCCGACCGGGAGGCCCTGCGGGCCGTGGTCGAGGGCCACGACGAGGTGGTGCACTTCGCGGCGGAGTCGCACGTGGACCGGTCGCTGCACGACGCGTCCGACTTCGTGCGGACCAATGTGGCGGGCACCCAGAGCCTCCTGGAGGCCTGCCTGCGGGCCGAGGTGCGGCGCGTCGTGCACGTCTCGACCGACGAGGTGTACGGCTCGATCGAGTCCGGCGAGTGGACGGAGTCCAGTCCCCTGCTGCCCAACTCCCCCTACGCCGCGACGAAGGCGAGCGGAGATCTGATCGCCCGCGCGTACTGGCGCAGCTACGGTCTGGACGTCCGCGTCACGCGGTGCAGCAACAACTACGGCCCGTACCAGCACGTCGAGAAGCTGATCCCGCTCTTCGTCACCAACCTGCTCAGCGGGCGGAGCGTGCCGCTGTACGGGGACGGCAGGAACGTACGGGAGTGGGTGCACGTGGAGGACCACTGCCGCGCGGTGCAGCTCGCCCTCACCGAGGGCAGGGCGGGAGAGGTGTACAACGTGGGCGGCACCCCGCTGTCGAACCGGGAGATCACCGGTCAGCTGCTCGAGCTGTGCGGAGCCGACTGGAGCCGGGTCCGGCCCGTCGAGGACCGCAAGGGGCACGACTTCCGGTACTCCGTCGACGACACGAAGATCCGGACCGTGCTGAGCCACCGTCCGAGGGTCTCCTTCCGGCAGGGCCTGGCCGAGGTGGTCCGGTGGTACCGGGAGAATCCGGGCTGGTGGCAGCCCCTGCGTACGTCCTGA	MGVHAVRVLVTGGAGFIGSCYVRALLDGAYPGYEDAQVTVVDKLTYAGNRANLPERHERLRFVVGDIADREALRAVVEGHDEVVHFAAESHVDRSLHDASDFVRTNVAGTQSLLEACLRAEVRRVVHVSTDEVYGSIESGEWTESSPLLPNSPYAATKASGDLIARAYWRSYGLDVRVTRCSNNYGPYQHVEKLIPLFVTNLLSGRSVPLYGDGRNVREWVHVEDHCRAVQLALTEGRAGEVYNVGGTPLSNREITGQLLELCGADWSRVRPVEDRKGHDFRYSVDDTKIRTVLSHRPRVSFRQGLAEVVRWYRENPGWWQPLRTS	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.24	gnl|BL_ORD_ID|1549|hsp_num:0	1643		
BGC0001439.1|Cervimycin_26 # 31227 # 32258 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.766	BGC0001439.1|Cervimycin_26 	31227	32258	-	Loose	400	25.409	Erm(30)	68.75	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAGTGAGTCAGCGAGCGAACGCCCGCGCCGGGTGGCCCTGTTGCTGCCCGGCCAGGGCGCCCAGTACCGGCGCATGGGCATGGGCCTGTACACGTCCCAGCCGGTCTTCGCCGAAACGATGGACGAGGTCTTCGCCGCCATGGGCGCGGCGGGGCCGGCACTGCGCGCCGACTGGCTCGCCGAGCGGCCGTCGGTTCCGGTGGAGTCCGCGGCCTGGGCCCAGCCGCTGCTCTTCGCCGTGGACGTCGCCCTCGGCCGGCTGCTGATGAGCTGGGGCATCGAGCCGGCCGCGCTCCTCGGCCACAGTGTCGGCGAGCTGGCGGCGGCCGTGCTCGCCGGCGTCTTCGGGCTCCGGGACGCCACCGCTCTGGTCCTCGACCGGGTCTCCAGGGTGGCCGCCGCGCCGCCGGGCGGGATGCTCGCGGTGGCGGCGACCCGGGCGGAGGTGGAGCCGTTCCTGGCCGGGAACGTGGTGATCGGCGCGGTCAACGCGCCGCGGCACACCGTGCTCGCGGGACCGCGGGAACCCCTGGCCGAGACGGCCCGGCAGCTCGACGCCAACGGCCTCAGCAGCCGTCCCGTGCCCTCGCACACCGCCTTCCACAGCCCGGTGCTGGCCCCGTGCCTGGCGGGCGCCGACGAGCGCGTCGCCGCCACGGCGCGCAGACCACCGCTGATCACGGTGTACTCCGGGTACACCGCGGCCCCGCTGGGCGCCGCCGAAGCGCTCGATCCGGGCTTCTGGGCACGGCAGCCGATGGCTCCCGTGCTGTTCTGGCCCGCGCTCGACGCCCTGCTGTCCTCGGGCGACCACGTGCTGGTGGAGGCCGGCCCGGGGCGCGGCCTGGGCAGCATCGCGCGCCGGCATCCCGCGGTCCGGCGGGGTGCGAGCAGCGTCGTCACGTTGCTGCCGAGCGGTCCCGGCGACGGCGGCCGGGACCGCCTCGCCCTGCGTGCGGCGGCCGAGGCGCTGCACGCCGAAGGTTTCGTGAGGGCCGGCATCTCCTGCCGGAGGGCGGCCGCTTCCTAG	MSESASERPRRVALLLPGQGAQYRRMGMGLYTSQPVFAETMDEVFAAMGAAGPALRADWLAERPSVPVESAAWAQPLLFAVDVALGRLLMSWGIEPAALLGHSVGELAAAVLAGVFGLRDATALVLDRVSRVAAAPPGGMLAVAATRAEVEPFLAGNVVIGAVNAPRHTVLAGPREPLAETARQLDANGLSSRPVPSHTAFHSPVLAPCLAGADERVAATARRPPLITVYSGYTAAPLGAAEALDPGFWARQPMAPVLFWPALDALLSSGDHVLVEAGPGRGLGSIARRHPAVRRGASSVVTLLPSGPGDGGRDRLALRAAAEALHAEGFVRAGISCRRAAAS	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	102.08	gnl|BL_ORD_ID|1153|hsp_num:0	1224		
BGC0001439.1|Cervimycin_27 # 32287 # 33195 # -1 # ID=1_27;partial=00;start_type=TTG;rbs_motif=CGA;rbs_spacer=15bp;gc_cont=0.681	BGC0001439.1|Cervimycin_27 	32287	33195	-	Loose	675	30.0314	emrA	29.47	3000027	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGATAGCCGCGCCCGTCGACGTCGTGCGCCAGATCGTGGTCGATGTCGAGGCGTGGCCCCAGCTGCACGGGCCCGCGGTGCACGCGGAGATCCTGGACAGCGGTGCCGACGGCGATGTGATCCAGCACTGGTCGGTCGTGGACGACCACACCGTGCGGACGTGGGTGTCCCGGCGCACGGTCCTCGGCTCGGGCGACGTGCTGTTCACGCACGAACCCGCGAACGCCCCCTTCGCGACGGTGGGCGGAGGCTTCGCGTTCGAGGAGCAGCCGGACGGTGCCACCCTCGTGCGTATGCACCACGAGTTCGCCCTCCTCCAGGAGGACGACCAGGTGGCCGCCGGGCGCGCGCAGTCCATGCAACGCGGGAGCCAGGAGTACCTGAAGACCCTGAAGTACGCGGCGGAGAACGCCGACGAGCTGCGGCAGCTGATCATCTCCTTCGAGGACCCGCTGTTCGTGGCGGGGTCTGTCGAGGACGCCTACCGGTACCTGTACGAGGCGGACAAGTGGCCGGAGCGGATTCCGCACGTGATCCGGCTGGAACTGGAGGAGAACACACCGAACATCCAGTTCTTCGACATGGACACACGCTCCTCGGACGGCTCGGAGCACACCACGCGCTCGGTCCGGATCTGCCTGCCGAACCACAAGATCGTCTACAAGCAGACCCGGCCGCCCAGGACCCTGGACGCGCACACCGGCCACTGGCTGTTCACGCCGACTCCGGAGGGTGTCGTCGTCAGCGCCCGGCACACGGCGACGATCCGGCCCCAGGGTCTGCACCTGCTGGGTGAGGGCACGACGGTGGAAGGAGCCCGCAGGTATCTGCGCCGCATCCTGAGCGCCAACAGCATGGGCAATCTGCGGCTGTCCAAGGAGTACGCCGAGCGACTGGCCGGACACTGA	MIAAPVDVVRQIVVDVEAWPQLHGPAVHAEILDSGADGDVIQHWSVVDDHTVRTWVSRRTVLGSGDVLFTHEPANAPFATVGGGFAFEEQPDGATLVRMHHEFALLQEDDQVAAGRAQSMQRGSQEYLKTLKYAAENADELRQLIISFEDPLFVAGSVEDAYRYLYEADKWPERIPHVIRLELEENTPNIQFFDMDTRSSDGSEHTTRSVRICLPNHKIVYKQTRPPRTLDAHTGHWLFTPTPEGVVVSARHTATIRPQGLHLLGEGTTVEGARRYLRRILSANSMGNLRLSKEYAERLAGH	MSANAETQTPQQPVKKSGKRKRLLLLLTLLFIIIAVAIGIYWFLVLRHFEETDDAYVAGNQIQIMSQVSGSVTKVWADNTDFVKEGDVLVTLDPTDARQAFEKAKTALASSVRQTHQLMINSKQLQANIEVQKIALAKAQSDYNRRVPLGNANLIGREELQHARDAVTSAQAQLDVAIQQYNANQAMILGTKLEDQPAVQQAATEVRNAWLALERTRIISPMTGYVSRRAVQPGAQISPTTPLMAVVPATNMWVDANFKETQIANMRIGQPVTITTDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDQKQLEQYPLRIGLSTLVSVNTTNRDGQVLANKVRSTPVAVSTAREISLAPVNKLIDDIVKANAG	77.44	gnl|BL_ORD_ID|1656|hsp_num:0	1757		
BGC0001439.1|Cervimycin_28 # 33428 # 33868 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0001439.1|Cervimycin_28 	33428	33868	+	Loose	700	23.483	Klebsiella pneumoniae KpnG	64.29	3004588	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGCACAGAGCAGGTGGCCGAGCGCGTGACCGCCGAGGTCTACGCGGAGGTACAGCAGTTCTACGCCGAGCACATGCAACTGCTGGACGGCGGGGCCGTGGACGCCTGGGCGGAGACGTTCACCGAGGACGCGACCTTCGCCGTACCGACCCTGCCGGAGCCGACGCGCGGCCGGCGAGGGCTCAGGGAGGCGCTGAGTCGCACCACACGGGAGCTGGCGGCGGCGCGGGAGCGGCGCCGCCACTGGCACGGGATGGTCGCGGTGTTCCCGAACGGGGACGGATCGCTGCGCGTGCGGTGCTACGCCCTGGTGTTCGCGACCCGGCTCGAGCAGCAGCCGGTGCTGCACCGCGTCTGCGTCTGCGAGGACGTGCTGGTCCGGGAGGGCGGCCGGCTCCTGGTGAAGAGCCGCGAGGTCACCCGGGACGACCTGCCGTAG	MSTEQVAERVTAEVYAEVQQFYAEHMQLLDGGAVDAWAETFTEDATFAVPTLPEPTRGRRGLREALSRTTRELAAARERRRHWHGMVAVFPNGDGSLRVRCYALVFATRLEQQPVLHRVCVCEDVLVREGGRLLVKSREVTRDDLP	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALSQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	37.44	gnl|BL_ORD_ID|2790|hsp_num:0	3298		
BGC0001439.1|Cervimycin_29 # 33931 # 34704 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=CGA;rbs_spacer=14bp;gc_cont=0.696	BGC0001439.1|Cervimycin_29 	33931	34704	-	Loose	150	25.0238	dfrB6	25.37	3003023	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGCGCATCATCGACCTGTCCACGCCGATCGATGCCGGTGTCTGGGAGCCGAATCCGGTCGAGCACGAGGTCATGTCGCCTGCGGAGGGCGGTCGGCACATGGCCGAGGGCATGCGGGAGCGGTACGGCCTGGAGTTCGACCCGGCCGACCTGCCGGGCGGCGAGCTGCTGTCGCTCGACACGGTCAGGCTGACCACCCACACCGGAACGCACGTCGACGCCCCGTCCCACTACGGCTCGACGGCGGCGTACGGCGAACCGCGCCACATCGACCGGATGCCGCTCGACTGGTTCGTACGTCCCGGCATGGTGCTCGACCTGACAGACGAACCCGTGGGGGCCGTCGGTTCCCACGTCCTGCGCCGTGAGTTCGAGCGGATCGGCCGGGAACCGCGGCCGATGGACATCGTCATGCTGAACACCGGCGCGGACCGGATCGCCGGAACCCCGAAGTACTTCACGGACTTCACGGGTCTCGACGCCTCGGCGACGCATCTCCTGCTCGACCTCGGGGTGAAGGTGATCGGCACCGACGCGTTCAGTCTGGACGCGCCGTTCACGTACATGATCGAGGAGTTCCGCCGCACCGGCGACCGCGGTGTGCTGTGGCCCGCGCACTTCGTGGGCCGTGAGCGCGAGTACTGCCAGATCGAGCGGCTCGCCAACCTGGACGCGCTGCCCGCCGACACGGGGTTCACGGTCTCGTGCCTGCCCGTGAAGCTGGTGAACGCCGGGGCGGGCTGGGCACGGGCCGTCGCGCACGTGGAGGAGTGA	MRIIDLSTPIDAGVWEPNPVEHEVMSPAEGGRHMAEGMRERYGLEFDPADLPGGELLSLDTVRLTTHTGTHVDAPSHYGSTAAYGEPRHIDRMPLDWFVRPGMVLDLTDEPVGAVGSHVLRREFERIGREPRPMDIVMLNTGADRIAGTPKYFTDFTGLDASATHLLLDLGVKVIGTDAFSLDAPFTYMIEEFRRTGDRGVLWPAHFVGREREYCQIERLANLDALPADTGFTVSCLPVKLVNAGAGWARAVAHVEE	MDQGSNEVINPVAGQFASPSNATFGMGDRVRKKSGAAWQGQIVGWYSTKLTPEGYAVESEAHPGSVQIYPVAALERVN	329.49	gnl|BL_ORD_ID|668|hsp_num:0	710		
BGC0001439.1|Cervimycin_30 # 34714 # 36369 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0001439.1|Cervimycin_30 	34714	36369	-	Loose	900	145.206	iri	32.56	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAACGCGATATCCAGTGACGTCGACGTGCTGGTCGCCGGGGCTGGGCCGGTCGGGCTGACAGCCGCGTACGAGCTCGTGCGCCGAGGCGTACGGGTCCGGGTCGTGGACCGGGCCGAGGGGCCGGCGACGACGAGCCGTGCGACGGCCACGCATGCCCGAACGCTTGAGGTGTACCACCAGATGGGCATCCTGCGGGAGCTGCTGGCTCGCGGGCAGCGCGTGGAGAACTTCACCATGCACCGCAGGGGCCGGGTGCTGACCAGCCTCGGCACGGACTACTCGGAGCTGCCCACCCGCTATCCGTTCACGCTCCAGGTCGACCAGGTCATCACCGAGGAGGTGCTGCGGGAGCAGTTGCGCGCGGCCGGCGTCGACGTGGAGTGGGGTGTCGCGCTGGAGAGCCTCGACAACGCGCCGGACGGCGTCGTCGCCCGGCTTCGCCACCCTGACGGCCGCGACGAGGAGTACGCGGTCGGGTGGCTGGTCGGCGCCGACGGTGCGCACAGCACGGTGCGCAAGCAGCTCGGCATCGATCTGCTCGGCGAGTCTTCGGAGAAGTGGATGGTGGCCGACGCCTTCATCGACACGGAGCTGCCCCGGGACAGCCTGCACTGGATGCATCTGTCACGAGGAACCATCCTCATGGTGCCGTTCCCCGACGAGGGCAAGTGGCGGCTGCTGGACACGGACGATGTCGGCGACGAGGACCGGCCGGACGTGGTGCGGGCCCGGTTCGAGGCGAAGATGTCCGAGGGGCTGGGCAGGCCGGTCAGGGTCAAGGAGCTGACCTGGATGTCGGTGTTCACGATCCGGCAGCGGATGGTGGAGAGCATGCGCTCCGGCCGCTGCTTCCTGGCCGGCGACGCGGCACATGTGCACAGCCCGGCGTCCGGGCAGGGCCTGAACACCGGTGTCCAGGACGCCTACAACCTCGCGTGGAAGCTGGCCTCCGTGGTCAACAGGCAGGCCGCGGAGGGCCTGTTGGACAGCTACAGCGCCGAGCGGGTGCCCGTCGGCGAGATCCTGCTGGGCTCCACGAAGACCGCCACGAAGCTGATCGCGCTGCGCAACGCGGCCGCTCCCGTCCTGCTGCCGGTGGGCATGGCCCTGCTCAATCTGCTGACGCCGGTCAAGCGCGGAGTGGAGCGCAAGATCCTGCGCGGCATGTCCGGGCTCGCGCTGCACTATCGCTCCAGCCCGCTCACCGTCCCGGCGCGGCCGGACGCGGGTGGCGACGCCGGGATCCAGCCGGGCGACCGGGTCTCCTGCTCCCGGGAGGAGCTGAGCGCCGCCCCGGGCTGGCAGGCGGTGTGCGAGGAACTGGCCGACCCTCGGTGGATGTTGCTCGTCTTCGCCGGCCCCGGCGCCGTTCCGGAAGCGGCGCGGCGGGCTCACCGGACGTACGGGGACGCGCTGCGCGTGAGGGTCGTGCGCGAGACGGAGGCGAGCGCACGGGACGCCGGGCCCGAGCCCCTGCACGACCCGGAGGGCCGGGTGCGGCGCGCCTTCGCCCTCGCGGCCGGGACCTCGTACGCCCTCGTACGGCCGGACGGCCATCTGGCCGCCAAGGGGCCGCTCGCCGGCGAAGCCGCGCTGGAGAGCCTGCTCCGGCGCGTCCATCTGCTACCCACCCGCCGCGGCGTGGCGAAGTAA	MNAISSDVDVLVAGAGPVGLTAAYELVRRGVRVRVVDRAEGPATTSRATATHARTLEVYHQMGILRELLARGQRVENFTMHRRGRVLTSLGTDYSELPTRYPFTLQVDQVITEEVLREQLRAAGVDVEWGVALESLDNAPDGVVARLRHPDGRDEEYAVGWLVGADGAHSTVRKQLGIDLLGESSEKWMVADAFIDTELPRDSLHWMHLSRGTILMVPFPDEGKWRLLDTDDVGDEDRPDVVRARFEAKMSEGLGRPVRVKELTWMSVFTIRQRMVESMRSGRCFLAGDAAHVHSPASGQGLNTGVQDAYNLAWKLASVVNRQAAEGLLDSYSAERVPVGEILLGSTKTATKLIALRNAAAPVLLPVGMALLNLLTPVKRGVERKILRGMSGLALHYRSSPLTVPARPDAGGDAGIQPGDRVSCSREELSAAPGWQAVCEELADPRWMLLVFAGPGAVPEAARRAHRTYGDALRVRVVRETEASARDAGPEPLHDPEGRVRRAFALAAGTSYALVRPDGHLAAKGPLAGEAALESLLRRVHLLPTRRGVAK	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	115.03	gnl|BL_ORD_ID|750|hsp_num:0	796		
BGC0001439.1|Cervimycin_31 # 36508 # 38130 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=CCGCG;rbs_spacer=14bp;gc_cont=0.716	BGC0001439.1|Cervimycin_31 	36508	38130	+	Loose	960	28.1054	cmeC	36.84	3000785	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidic acid	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCAACCACCGATTCCGTGAGCACCACGAGCTCGGCCATGGCGGGACCGCCGCTCGACACCATCGCCCACCTGATCGCCGGCCCCCGGGTCGACCACATCCTGCGCCGGGCGGCGGAGCGCCGGCCCACCCGCACCGCGCTGCGTTCCCCGGGCGGTGAGACCAGCTACGCGGAGCTGGACGCGGCGGCGGACGCGTTCGCCGCCGGCCTGCGCGCCCTGACCGGCAGGACGGGGGAGGTCGTCGCCCTGGCGATGGTGCTGGACCCCGTGTTTCCCCGGGCCTTCTTCGGCATCGCACGCTCCGGCAACGTCAGTGCCCTGGTCAACCCGCTGCTCCCGCCGGAGCGCCTCGCCCACGTCCTGCGTGTCTCCGGGGCCCGCGTGGCTGTCGTCAGTCCCGCGATGGTGCCCGTACTCAGCGCCGTACGGGACCGGCTCGGCGACCTGGAGCACCTGGTGCTGACGCACCGCGAACCGGACACGGCGGGGGAGGCGGCCGAACTTCCCACGGTCGCCGAACTGTCGCAGGGCGCTCCCGCGTTCACACCGCCCCTGGAGGCGGATGACGACGAGGTGGCTTGTCTTCAGTTCACCAGCGGCACCACGGGAGCGGCCAAGGCCGTCCGGCTCACCCACCGCAATCTCACCGTCAACGCCGCCCAGACCGCGTACATGCACCAGGTCGACGAGGATTCGGTGCTCTTCAACCATCTGCCGACGTTGCACCTGATGCATGTCACGGTGGCCGCCACCGTCGGAGCCACCCATGTGCTGTGGCCCGGCGCCGACGTGGCCGAAGCCGTCACCGCCGCGGACGTCGCCAGAGCCACGCACTACTACAGCCTGCCGATGCGGCTGGCCAAGCTCGCCTGCGACCCCCGGCTCGGCGAGTTGGAGGCTCCCGCCCTGCGTGCCATCCTCTCGGGCGGCTCCGCCCTGGCCCCCAGTGCGGCCGGCGTGCTCAGCCAGCACTTCGGCGTACCGGTCGTCCAGGGCTACGGACTGGCGGAGACCTCGCCCACCACCCACCTCTCCGATCTCGACCGCCCCAGGCCCGGATCCTGCGGTGTGCTGGTCCCGGGCGGCGAGAGCCGGATCGTCGACCCGGAGACCCGGGCCACCCTTCCGGTCGACGCGTGGGGCGAGATACAGGTGCGCGGCCCCCAGCTGATGCTGGGCTACCTCGGACGCGACCTGTCCCACGACGTCGACGCGGACGGCTGGTTCTCCACGGGGGACATCGGCTACACGGAACCCACCGGGCACCTGTTCGTGGTCGACCGGATCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTGTCGCCGACGGAGATCGAGCGGGTCCTGCTCAGGCACCGTGCCGTCGCCGACTGCGTCGTCGTGGACGTCCCGCACGAGCTGAGCGGCGCGGTCGCACACGCACTGGTCGTGCCCGCCGACGCCTCCTGCACACCGCGCGAACTCATGGACTTCGTGAACGCGGAGGTCGCCGAGTACGAGCGGCTGCACCACGTGGCGCTGGTCGAGAGCATCCCGCGTTCCGCCACCGGCAAGGTGCAGCGCCGCGAGCTGCGCGACCGGCACGTGCGCGGCCTTCGTACGAGCGACCTGAACGTCTGA	MATTDSVSTTSSAMAGPPLDTIAHLIAGPRVDHILRRAAERRPTRTALRSPGGETSYAELDAAADAFAAGLRALTGRTGEVVALAMVLDPVFPRAFFGIARSGNVSALVNPLLPPERLAHVLRVSGARVAVVSPAMVPVLSAVRDRLGDLEHLVLTHREPDTAGEAAELPTVAELSQGAPAFTPPLEADDDEVACLQFTSGTTGAAKAVRLTHRNLTVNAAQTAYMHQVDEDSVLFNHLPTLHLMHVTVAATVGATHVLWPGADVAEAVTAADVARATHYYSLPMRLAKLACDPRLGELEAPALRAILSGGSALAPSAAGVLSQHFGVPVVQGYGLAETSPTTHLSDLDRPRPGSCGVLVPGGESRIVDPETRATLPVDAWGEIQVRGPQLMLGYLGRDLSHDVDADGWFSTGDIGYTEPTGHLFVVDRIKDVFKCDNWLVSPTEIERVLLRHRAVADCVVVDVPHELSGAVAHALVVPADASCTPRELMDFVNAEVAEYERLHHVALVESIPRSATGKVQRRELRDRHVRGLRTSDLNV	MNKIISISAIASFTLLISACSLSPNLNIPEANYSIDNKLGALSWEKENNSSITKNWWKDFDDENLNKVVDLALKNNNDLKLAFIHMEQAAAQLGIDFSSLLPKFDGSASGSRAKTAINAPSNRTGEVSYGNDFKMGLNLSYEIDLWGKYRDTYRASKSSFKASEYDYEAARLSVISNTVQTYFNLVNAYENENALKEAYESAKEIYRINDEKFQVGAVGEYELAQARANLESMALQYNEAKLNKENYLKALKILTSNDLNDILYKNQSYQVFNLKEFDIPTGISSTILLQRPDIGSSLEKLTQQNYLVGVARTAFLPSLSLTGLLGFESGDLDTLVKGGSKTWNIGGNFTLPIFHWGEIYQNVNLAKLNKDEAFVNYQNTLITAFGEIRYALVARKTIRLQYDNAQASEQSYKRIYEIAKERYDIGEMSLQDYLEARQNWLNAAVAFNNTKYSYANSIIDVIKAFGGGFEQSEDTSKNIKEESKNLDMSFRE	109.76	gnl|BL_ORD_ID|752|hsp_num:0	798		
BGC0001439.1|Cervimycin_32 # 38183 # 38485 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0001439.1|Cervimycin_32 	38183	38485	+	Loose	450	26.5646	SLB-1	27.5	3003556	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	SHW beta-lactamase	ATGCACCACTTCATCAACCGCTACACCGTGTCCGGCGACGTCACCGAGTTCCGCAGGCTGCTCGCCGAGTTGTCCGCCCACATGAGGGCCCAGCCCGGCTTCTCGGCACACCGCCTGTACCGGTCCGCGAAGGACGAGCGGACGTACGTGGAGGTCGCCGAGTGGACCGACCCCGAGTCGCACCGCAACGCGCTCTCGGCCGACGGCTTCCTCGGCCCGGTGGCCGAGCTGCGCAAGCACGCCACCGCGGAGCCGGCCCCGTTCGAGCTGCTCTCCGAGCACTCCGTACCCGCGTCGGAATAG	MHHFINRYTVSGDVTEFRRLLAELSAHMRAQPGFSAHRLYRSAKDERTYVEVAEWTDPESHRNALSADGFLGPVAELRKHATAEPAPFELLSEHSVPASE	MLSLPSYSHEVEPTSTTIQSVTSSLEGQLSISKLADGVYLHHSYKNVSNFGLVEANGLVVIKDKQAFIIDTPWTDNDTQKLVDWITQQGFIPVASISTHSHQDRAGGIGYLNRQGITTTVSETTQQILTENDKTTAKSTFTGMQYIMKTDLVEVYDLGAGHTKDNLVVWLPTQQILFGGCLIKSLNSSTLGYTGEADLQQWPLTIAKVQAQFPQVKIVVPGHGQVGDKALLEHTIELLIPKNETVNSSS	40.16	gnl|BL_ORD_ID|390|hsp_num:0	419		
BGC0001439.1|Cervimycin_33 # 38532 # 40064 # 1 # ID=1_33;partial=00;start_type=TTG;rbs_motif=CCG;rbs_spacer=14bp;gc_cont=0.699	BGC0001439.1|Cervimycin_33 	38532	40064	+	Loose	800	27.7202	msrA	28.89	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	TTGAAGGAGCTGAGCGGCCTCAAGGAGCTGGCCCGGCAAGGGCCGGACCCGGGAGCCACCGAACGCCAGCACGCCAAGGGCAAGCTGACGGCCCGCGAGCGGATCGAACTGCTGCTGGACGGGGGGAGCTTCACGGAGATCGAGCCGCTGCGCATGCACCGCGCGACCGGCCTCGGGCTCGAGGCGCGGCGTTACTACACCGATGGTGTGATCACCGGCTGGGGCACCGTGGAGGGGCGCACGGTCTTCGTCTGCGCCCATGACTTCCGGATCCTCGGCGGCACACTCGGCGAGGCGCACGCCGAGAAGATCCACAAGATCATGGACATGGCCGTGGCGGCGGGCGCTCCGCTGGTCTCGCTCAACGACGGGGCCGGTGCGCGCATCCAGGAAGGCGTTCTGGCGCAGGCCGGATACGGCGGGATCTTCCGGCGTCACAGCAGGGCGTCGGGTGTCATCCCGCAGATCAGCGTCATCCTCGGCCCGTGCGCCGGTGGCGCGTCCTACGGGCCCGCCCTGACCGACTTCGTCTTCACCGTGCGGGACCTCTCCCAGATGTTCATCACCGGTCCCGACGTGGTGCAGGCCGTGACCGGCGCGGAGGTGACGCTGAACGGACTGGGCGGCGCGGACGTCCATGCCGAGGTCTCGGGGGTGGCGCACTTCCTGTACGACGACGAGGAGACCTGTCTCGCCGAAGTGCGCTACCTGCTCTCCCTCCTGCCGTCGAACAACCGGGAACTGCCGCCCGCCGTGTCCTGCGGCGACCCCGCCGACCGGCTCTGCGAGGCCGTGCTGGACCTGGTCCCCGCCGACGGCAACCGCTCCTACGACATCCGCCGGGTGATCGGGGAACTCGTCGACGACGGTGACTTCATGGAGGTCCACGCCGGGTGGGCCCCCAACATCGTCTGTGCGCTGGCCCGCATGGACGGACAGACGGTGGGGGTGGTCGCCAACCAGCCCACCGTCATGGCCGGCGTGCTGGACATCAAGGCCAGCGAGAAGGGGGCGCGGTTCGTGCAGTTCTGCGACGCCTTCAGCGTCCCGCTGGTCACCCTCGTCGACGTGCCGGGCTTCCTCCCGGGTGTCGACCAGGAACACGAGGGGATCATCCGGCACGGCGCCAAACTGCTCTACGCGTACTGCAACGCCACCGTGCCGCGTGTCTCGGTGGTGCTGCGCAAGGCGTACGGCGGCGCGTACATCGTGATGGACTCCCGCTCCATCGGCGCGGACGTCGCACTGGCGTGGCCGGGCAACGAGATCGCCGTCATGGGGGCCGAGGGCGCCGCCAACGTGGTGTTCCGCCGTGACATCGCCGAGGCCGAGGACCCCGAGGCGATGCGCCGACAGAAGATCGAGGAGTACCGGCGCGAGCTGGTGCATCCCTACTACGCCGCCGAGCGGGGTCTCGTCGACGACGTCATCGACCCGCGCGAGACCCGGGCGACGCTGATCCGCACGCTCGCCATGCTGCGGGCCAAGGATGCCGAGCCGCCGCGTCGCAAGCATGGAAATCCGCCGCACTGA	MKELSGLKELARQGPDPGATERQHAKGKLTARERIELLLDGGSFTEIEPLRMHRATGLGLEARRYYTDGVITGWGTVEGRTVFVCAHDFRILGGTLGEAHAEKIHKIMDMAVAAGAPLVSLNDGAGARIQEGVLAQAGYGGIFRRHSRASGVIPQISVILGPCAGGASYGPALTDFVFTVRDLSQMFITGPDVVQAVTGAEVTLNGLGGADVHAEVSGVAHFLYDDEETCLAEVRYLLSLLPSNNRELPPAVSCGDPADRLCEAVLDLVPADGNRSYDIRRVIGELVDDGDFMEVHAGWAPNIVCALARMDGQTVGVVANQPTVMAGVLDIKASEKGARFVQFCDAFSVPLVTLVDVPGFLPGVDQEHEGIIRHGAKLLYAYCNATVPRVSVVLRKAYGGAYIVMDSRSIGADVALAWPGNEIAVMGAEGAANVVFRRDIAEAEDPEAMRRQKIEEYRRELVHPYYAAERGLVDDVIDPRETRATLIRTLAMLRAKDAEPPRRKHGNPPH	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	104.51	gnl|BL_ORD_ID|1132|hsp_num:0	1200		
